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Ribozymes are ribonucleic acid (RNA) enzymes capable of catalyzing chemical 
reactions. Their ability to catalyze reactions is dependent on the formation of proper secondary 
and tertiary folds. RNA folding begins as the nascent RNA is being synthesized. Structures that 
are formed early by the 5′ RNA will rearrange, allowing for more mature folds to take hold once 
the full-length RNA is synthesized. The final fold is the result of constant shifts in RNA structure 
as the RNA travels through its rugged folding pathway, until the full RNA has been synthesized 
and the RNA has reached its thermodynamically stable structure. In this dissertation, the folding 
dynamics of two RNAs, the bacterial 16S ribosomal RNA (rRNA) and the twister ribozyme, are 
studied. The 16S rRNA undergoes many conformational changes during 30S ribosome assembly, 
including a critical structural rearrangement during late stage of 30S subunit biogenesis between 
two competing structures, helix 1 and a hypothesized alternative helix 1. Using biochemical and 
analytical techniques, helix switching that occurs between the competing helical structures 
during 30S subunit reconstitution is examined.  Unlike the large 16S rRNA, the Twister 
ribozyme is a small RNA that undergoes dynamic structural changes required for self-scission. 
The folding dynamics of twister RNA were measured in real time using single molecule Förster 
resonance energy transfer (smFRET). A photo-activatable chemical group, called a photocage, 
was able to trap the twister RNA in its secondary fold. Tertiary folding was temporally 
controlled by activating the photocage with a 405 nm laser. By controlling when secondary and 
tertiary folding occurred, folding behavior before and after tertiary interactions formed and self-
scission occurred can be monitored directly. Studying this dynamic behavior has provided 
insight into the rate of folding and how environmental conditions influence its folding dynamics. 
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Understanding RNA dynamics is critical for understanding RNA function and creates a future 
opportunity for predicting RNA folding and function from its sequence.  
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Chapter 1: RNA Folding 
Introduction 
 RNA is a versatile molecule capable of storing information as well as performing 
catalytic functions required for survival. This versatility has made it a prime candidate for being 
the first polymer to arise in an abiotic environment, leading to the RNA world hypothesis 
(reviewed in (Higgs and Lehman 2015)). This hypothesis relies on the idea that RNA or RNA-
like molecules arose at the beginning of life that were capable of storing information and 
catalyzing self- replication. Today, RNA continues to perform catalysis but is relied upon to a 
smaller degree. DNA has evolved as a more stable means of storing information, while proteins 
are capable of rapid, controllable, catalysis. Messenger RNAs (mRNAs) are used to store and 
transfer information, while ribonucleic acids enzymes or ribozymes are used to perform peptidyl 
transfer reaction in the ribosome, splicing of mRNAs, and signal transduction via metabolite 
sensing and self-cleavage.  
 Information carried by RNA is within its primary sequence, the nucleotide sequence that 
is read by the ribosome while synthesizes proteins, or by reverse transcriptase while synthesize 
complimentary DNA (cDNA). However, the catalytic activity of RNA arises only when it takes 
on a proper secondary and tertiary structure. This folding happens in stages and is done as soon 
as the RNA starts to be synthesized by RNA polymerase or co-transcriptionally (reviewed in 
(Schroeder et al. 2002; Ganser et al. 2019)). The folding of RNA is a complex process, with its 
local secondary structural folding occurring in parallel with its tertiary fold, which arises from 
long range interactions (Schroeder, Barta, and Semrad 2004). Certain secondary and tertiary 
structures that fold initially during transcription will refold to bring about structures with lower 
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free energy during the RNAs journey through the folding landscape. Secondary folds are 
relatively stable and form due to Watson-Crick base pairing resulting in the formation of helices 
and loops. Most RNAs are treated as unfolded when they only contain secondary structures 
because these structures are so stable, and its rarely observed how an unstructured and unfolded 
RNA develops its secondary fold (reviewed in (Draper, Grilley, and Soto 2005)). Tertiary 
structures occur from distant RNA sequences coming closer together to stabilize a specific 
structure, resulting in the stabilization of an active site responsible for performing catalysis. 
Because the RNA has a negatively charged backbone, it is difficult to bring sequences together 
in a tertiary fold without the help of positively charged metal ions, proteins or other positively 
charged cellular metabolites such as spermine and spermidine.  
 
Metal ions stabilize tertiary folds 
 K+ and Mg2+ are the two most abundant ions within the cell (Romani 2011). Both of these 
ions have a role to play in stabilizing RNA structure by preventing the negative backbone from 
repulsing itself through their positive charge. Mg2+ is the smaller of the two ions and has the 
larger positive charge, making it great at stabilizing RNA structures. Previously it was thought 
that the metal ions worked by binding to specific sites within the RNA, stabilizing the binding 
site via induced fit, and allowing for the RNA to fold. Now it is much more accepted that metal 
ions play a general role in folding, by interacting with the RNA through electrostatic forces, and 
can influence both RNA folding and other ion binding long distances from the point at which 
they are located (Draper, Grilley, and Soto 2005). Increasing Mg2+ concentration has been 
documented to collapse the RNA structure into a condensed form that is not necessarily its native 
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fold (reviewed in (Woodson 2010)). However, by allowing RNA to form its condensed structure 
it might allow for the active site to refold, eventually ending up at the native, active structure. 
 The presence of Mg2+ is important for in vitro ribosomal 30S subunit reconstitution, as 
well for the in vitro folding and activity of most ribozymes. Twister ribozymes, a 
bioinformatically identified self-cleaving ribozyme family, are capable of folding in Mg2+ but 
have a lower midpoint of cleavage in the presence of other divalent metal ions such as nickel, 
cobalt and manganese, suggesting a preference for other metal ions (Roth et al. 2014; Panja et al. 
2017a). In order to understand the folding dynamics of twister under different metal ion 
concentrations, and to understand the effect these ions have on folding and cleavage, I attached a 
fast activating photocage to the ribozyme. Using single molecule fluorescence resonance energy 
transfer (smFRET) spectroscopy, I studied the dynamics of twister ribozyme from the very start 
of its ability to fold from secondary to tertiary structure, in the presence of varied concentrations 
of metal ions.  
 
Proteins can play a role in RNA folding 
 Unlike metal ions which work through passive means, proteins are capable of folding 
RNA in a more active manner (Schroeder et al. 2002). Although the functions of the ribosomes 
are performed by the RNA, proteins play a role in helping the RNA fold by either stabilizing or 
destabilizing specific folds and interactions (Weeks 1997). Most ribosomal proteins bind to 
ribosomal RNA and restructure the RNA and themselves. The initial protein-RNA or RNA-RNA 
interaction changes over the lifetime of the RNA-protein complex until it arrives at its native 
fold. While ribosomal proteins remain bound to the ribosomal RNA, other proteins, such as 
ribosomal assembly factors, are capable of binding, guiding folding, checking for proper RNA 
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dynamics and then dissociating from the complex. Proteins help guide the RNA through its 
folding landscape, allowing for quick folding of the RNA by preventing the stabilization of 
unproductive folded states. 
Defining the Ribosome 
The ribosome is a ribonucleoprotein complex that is responsible for the translation of 
messenger RNA (mRNA) to proteins. It is present in all domains of life, and the core of the 
ribosome is well-conserved from bacteria to humans (Melnikov et al. 2012). It is composed of 
two subunits, a large subunit and a small subunit, with each subunit itself being composed of 
both RNA and proteins (Noller 1991; Yusupov et al. 2001). The bacterial 70S ribosome is 
composed of small subunit (30S) and a large subunit (50S), all named after their sedimentation 
coefficients, which are measured in units of Svedberg (S) and describes their ability to pellet 
during ultracentrifugation. The E.coli 30S subunit is composed of a 1542 nucleotide (nt) 
ribosomal RNA (rRNA) and 20-21 ribosomal proteins (r-proteins) (Shajani, Sykes, and 
Williamson 2011). The 50S subunit is composed of two rRNAs, a 2,904 nt 23S, and a 120 nt 5S, 
with a total of 33 proteins (Moore and Steitz 2002). Each subunit plays a role in translating 
mRNA into proteins, and its proper function can only come about when the rRNA is properly 
folded. 
Within the 70S ribosome, the large subunit (LSU) contains the peptidyl transferase 
center, which is responsible for the synthesis of the nascent protein, making the ribosome a bona 
fide ribozyme (Noller, Hoffarth, and Zimniak 1992; Nissen et al. 2000). The small subunit (SSU) 
is responsible for binding mRNA, translocating, and accurately decoding it (Noller 1991; Carter 
et al. 2000). Proper folding of the rRNA is essential for all of these functions and the cell cannot 
survive without making sure that rRNA is folded, with most antibiotics targeting the ribosomes 
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ability to translate RNAs into proteins. Ribosomal proteins coat the rRNA, guide its folding, and 
support the binding of elongation factors during translation (Noller 2017). If the rRNA is 
misfolded, or a r-protein is under the stoichiometric amount within the cell, this can result in 
ribosomopathies. 
The rrn operons are highly regulated 
E.coli contain seven operons which code for the 16S rRNA, 23S rRNA and the 5S rRNA, 
with interspersed tRNAs (Sarmientos et al. 1983; Dahlberg 1999). Based on the environmental 
conditions, the total number of ribosomes present in a cell can vary between 20,000 and 70,000 
(Condon et al. 1999). This means that the cell has to transcribe, mature, maintain and then 
degrade thousands of ribosome complexes depending on the needs for its survival. The cell also 
maintains the levels of the rRNA, even in the presence of plasmid DNA containing different rrn 
operons (Brosius et al. 1981; Gourse, Boer, and S 1986). The concentration of r-proteins is also 
highly regulated, with many r-proteins participating in negative feedback loops to control their 
own synthesis (Razi and Ortega 2017; Torres et al. 2001).  
All three of the ribosomal rRNAs are transcribed as a single transcript and processed as 
they are being transcribed. In the absence of RNases, there is an accumulation of cistronic 
transcript containing all three rRNAs (Apirion and Gegenheimer 1981). This allows for equal 
amounts of each rRNA to be synthesized. Since the rRNAs are co-expressed as a cistronic unit, 
their synthesis can be co-regulated, particularly during transcription initiation and elongation by 
NusA and NusB (S. C. Li, Squires, and Squires 1984). NusA and NusB interact with regions 
upstream of the first rRNA gene containing anti-terminator loops (box A-C) and hairpin 











Figure 1:  E. coli rrn operon 
 
Structure of a typical rrn operon in E. coli. Blue boxes represent the coding regions of the 16S, 
tRNA, 23S and 5S. The cut sites for RNase III, RNase E, and RNase G are highlighted with 
vertical lines. The 115 nt 5′ leader sequence used in this study (5′LS) is highlighted by a red line 
and is located before the 16S sequence begins and starts at the RNase III cut site. The leader 
sequence containing boxes A, B, and C is removed by RNase III (S. C. Li, Squires, and Squires 
1984).  After the 16S coding sequence, a 33 nt 3′ trailer sequence in purple remains after RNase 
III cleavage. The combined 5′ LS, 16S, and 3′TS comprise the 17S rRNA. Two promoters, P1 





The rrn operons contain two promotor regions, P1 and P2, which have distinct 
mechanisms for responding to the metabolic state of the cell (Figure 1) (Sarmientos et al. 1983). 
Both P1 and P2 promoters are sensitive to the amino acid concentration within the cell, but the 
P1 promoter has a stronger response to the stringent response and the alarmone (p)ppGp 
(Sarmientos et al. 1983). By starving the cell of certain metabolites, ribosome synthesis can be 
halted at transcription initiation, and then restarted upon feeding to follow the kinetics of 
ribosome biogenesis in vivo (Hulscher et al. 2016). E. coli rrn operons are highly regulated to 
make sure that the proper amount of rRNA is available to match the growing needs of the cell, 
and to control the consumption of cellular energy and metabolites required to support ribosome 
biogenesis. 
30S subunit Biogenesis and Maturation 
 During transcription, the nascent RNA begins to fold and is processed by ribonucleases 
(Figure 1). The rRNA genes are separated by intergenic regions that are recognized by 
ribonucleases and processing occurs in several steps to generate mature rRNA species. Once the 
full-length sequence of the 16S rRNA has been transcribed with its terminal sequence, a hairpin 
is formed between the leader sequence and the terminal sequence which is recognized and 
cleaved by RNase III (Nikolaev, Silengo, and Schlessinger 1973; Young and Steitz 1978). The 
resulting cleavage product is called the 17S rRNA which contains a 115 nt 5′ leader sequence 
(5′LS) and a 33 nt 3’ trailing sequence (3′TS). Following RNase III cleavage, the 17S rRNA is 
recognized by RNase E, which cleaves the 17S rRNA within the 5′LS generating a shorter 5′LS 
that contains 66 nt upstream of the 16S. Finally, RNase G cleaves at the very start of the 16S 
rRNA to generate the mature 5′ end (Z. Li, Pandit, and Deutscher 1999). The 3′TS was found to 
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be processed independently of the 5′LS by multiple RNases, including PNPase and YbeY 
(Sulthana and Deutscher 2013; Jacob et al. 2013). 
The 16S rRNA is divided into four domains, the 5′ domain (nt: 1-561), central domain 
(562-916), 3′ major domain (917-1394), and 3′ minor domain (1395-1542.) As these domains are 
synthesized, they begin to fold with the help of r-proteins (Figure 2). Each domain is able to 
nucleate and fold independently of each other (Weitzmann et al. 1993). The RNA-RNA and 
RNA-protein contacts that occur during 16S folding, change as the molecules continues to be 
processed and matured (Stern et al. 1989). The first interaction a protein makes with the rRNA 
does not last, instead both change the others conformation as the 30S subunit matures. Some 
contacts that form initially refold as the 30S subunit takes form. An example of this is the folding 
of helix 3 in the presence of r-protein S4, where you can see the movement of helix 3 closer and 
farther to the protein, until it properly settles into its bound state (Kim et al. 2014).  
Although the upstream leader sequence of the precursor 16S rRNA gets processed away, 
it is believed that parts of that sequence participates in co-transcriptional folding of the 16S 
rRNA by behaving in a chaperone like fashion (Besançon et al. 1999). Mutations that have been 
made to the upstream region affect the melting of the 16S rRNA, while showing the proper 
processing of the rRNA. The upstream RNA makes intermittent contacts with the 16S rRNA, 
sequestering specific sequences from participating in folding thereby separating structure 
formation spatially and temporally. Mutations in box C result in cold sensitivity and poor 
growth, suggesting that there are interactions between the upstream sequence and the 16S rRNA 
(Figure 1) (Schäferkordt et al. 2001). These upstream mutations result in the proper sequence of 
the RNA being transcribed, but it is misfolded. Ribosomes which contain misfolded rRNA are 








Figure 2: Tertiary fold of the 16S rRNA with the mature 30S subunit 
On the left is the tertiary fold of the 16S rRNA without r-proteins shown (PDB: 4V7S) 
(Dunkle et al. 2010). The rRNA is color coded with the 5′ domain in blue, the central 
domain in purple, 3′ major domain in light pink and the 3′ minor domain in yellow. On the 
right is the mature 30S, with all of the r-proteins bound (PDB: 4V7S) (Dunkle et al. 2010). 
Primary proteins are colored in red, secondary proteins in green and tertiary proteins in 
blue. The position of the central pseudoknot, or helix 2, is highlighted by a square. It is 
positioned at the heart of the 30S, within the active site of the subunit.  
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toxic proteins (Roy-Chaudhuri, Kirthi, and Culver 2010). These examples demonstrate the co-
transcriptional folding and guidance of RNA folding by proteins and RNA sequences not present 
in the mature 30S subunit.  
Ribosomal proteins 
 Parts of the 16S rRNA are able to fold themselves in vitro in the presence of only salts 
and high temperature, but r-proteins are needed to stabilize the folded 16S rRNA in the cell 
(Adilakshmi, Ramaswamy, and Woodson 2005; Razi and Ortega 2017). The 21 different r-
proteins (S1-21) have been categorized into three classes: primary, secondary and tertiary, based 
on their binding ability and pelleting with the 16S rRNA during in vitro 30S subunit 
reconstitution (Figure 2) (Mizushima and Nomura 1970; Held et al. 1974). The primary binding 
proteins bind directly to the rRNA, while secondary proteins can only bind when one or more 
primary proteins are already present. Tertiary binding proteins were classified as those that bind 
after a required heat step during in vitro reconstitution (Masayasu Nomura and Held 1974). The 
binding of each protein changes the fold of the rRNA, allowing for the next class of proteins to 
recognize, bind and cooperatively fold the rRNA (Talkington, Siuzdak, and Williamson 2005; 
Williamson 2006). Although the proteins bind in a hierarchical fashion, assembly and folding 
can proceed through a number of parallel pathways to generate a mature 30S subunit 
(Talkington, Siuzdak, and Williamson 2005; Adilakshmi, Bellur, and Woodson 2008; Gupta and 
Culver 2014). 
Proteins are able to reorganize the rRNA as they bind and stabilize particular folds, while 
destabilizing non-native folds (Ramaswamy and Woodson 2009; Abeysirigunawardena and 
Woodson 2015). While S4 initiates nucleation by binding directly to the rRNA, S16 binds further 
away and destabilizes possible structures to allow for further on pathway folding of the 30S 
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subunit. Many ribosomal proteins have globular domains and disordered C-terminal tails. These 
tail penetrate the 16S rRNA and make contacts with them after they initially bind (Brodersen et 
al. 2002). As the pre-30S is matured, r-proteins that initially bind, change their structure, while 
changing reshaping the rRNA and vice-versa. 
30S subunit reconstitution in vitro 
Our earliest understanding of ribosome assembly came from efforts to reconstitute 30S 
subunits from their rRNA and protein components (M. Nomura 1968; Powers, Daubresse, and 
Noller 1993; Krzyzosiak et al. 1987). After purifying 30S subunits, it is possible to separate its 
components into native 16S rRNA and Total Proteins of 30S (TP30) which contains all the r-
proteins of 30S subunit (Masayasu Nomura and Held 1974; Dodd, Kolb, and Nomura 1991). 
Then by combining and incubating the components together at 42 ℃, functional 30S subunits 
can be formed (Nierhaus 1990; Powers, Daubresse, and Noller 1993). Reconstitution can also be 
carried out using recombinantly purified variants of each r-protein (Culver and Noller 1999). 
However, it was found that if you combine all of the recombinant proteins together, the 
reconstitution is not as efficient as with native proteins in TP30 and results in nonfunctional 
molecules that do not migrate at the same size as mature 30S subunit (Culver and Noller 1999). 
The same effect can be seen if a ratio of 1:4 of 16S rRNA to TP30 or higher is combined, 
because the r-proteins bind the rRNA nonspecifically stabilizing nonfunctional folds. Instead of 
combining all the proteins together, recombinant proteins can be split into their classes (primary, 
secondary, tertiary) and incubated with the RNA sequentially. This allows for the hierarchical 
binding and cooperative folding of rRNA. Magnesium concentration and temperature (42 ℃) are 
required conditions for assembly of the tertiary proteins such that assembly can proceed from a 
ribosomal intermediate (RI) to RI* (Masayasu Nomura and Held 1974). RI particles sediment at 
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the same time as 21S particles, and the higher temperature allows for RNA rearrangements to 
occur resulting in RI* particles capable of binding tertiary proteins. Interestingly, at low 
temperatures, the RI accumulates in vitro indicating that there is a thermodynamic energy barrier 
that needs to be overcome by either proteins in vivo or high temperature in vitro.  
Assembly Factors 
 In addition to 30S subunit ribosomal proteins, other proteins bind to the 30S ribosome 
during maturation but do not remain stably bound. These proteins are called assembly factors, 
which act to stabilize a particular fold or lower the activation energy for a particular structure and 
then must dissociate from the subunit before maturation is complete (Bunner et al. 2010; 
Woodson 2011). Assembly factors play an important role in promoting rapid and robust 
assembly of the ribosome under non ideal conditions. Assembly factors are not required for 30S 
subunit assembly in vitro, however they have been shown to aid assembly in vitro (Tamaru et al. 
2018). Many assembly factors are non-essential for cell viability, but genomic deletion results in 
an increase in 17S rRNA, 30S and 50S subunits, decrease in 70S ribosomes, and cold sensitivity 
(Shajani, Sykes, and Williamson 2011). All of these characteristics are thought to arise from 
misfolded variants of 30S subunit, suggesting that proper folding is essential for not only 
ribosomal function but also for maturation. There are more than 17 documented assembly factors 
involved in bacterial 30S subunit ribosome assembly (Shajani, Sykes, and Williamson 2011).  
 RbfA and RsgA are two examples of assembly factors which play an important role in 
the maturation of 30S subunit. RsgA is a GTPase, capable of removing RbfA from maturing 30S 
subunit (Goto et al. 2011). Deletion of RsgA results in slow growth under non ideal conditions, 
due to RbfA remaining bound to 30S subunit and preventing the small subunit from forming 
functional 70S ribosomes. It also plays a checkpoint role in 30S subunit maturation, where it can 
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bind and flip out the A1493 nucleotide to check for its ability to discern codon-anticodon pairing 
(Razi, Guarné, and Ortega 2017). RsgA has also been found to bind and destabilize certain folds 
within the 30S subunit (both rRNA and r-proteins), allowing it to overcome kinetic barriers 
(Pedro Lopez-Alonso et al. 2017). It’s possible for an assembly factor to use GTP to refold 
rRNA during maturation. 
RbfA (ribosome-binding factor A) is capable of binding to immature and mature 30S 
subunits and has been suggested to play a role in the transition that occurs between the pre-30S 
into 30S subunit (Jones and Inouye 1996; Inoue et al. 2006). It was originally identified as an 
unknown protein in the operon of initiation factor 2, but later established as an assembly factor 
(Sands et al. 1988). Because of its ability to rescue a cold sensitive mutation at the 5′ end of the 
16S rRNA, which was proposed to interfere with processing of the 5’LS, RbfA was predicted to 
bind directly to the mature 30S subunit (Cruz 1995). RbfA binds close of the 5′ end of 16S rRNA 
and is hypothesized to stabilize helix 1 using its C-terminus tail, allowing RNase G to cleave the 
5′LS (Datta et al. 2007). RbfA binds to only 30S subunit and is not found in 70S or polysome 
fractions, hinting at it being a late stage assembly factor. Further work has highlighted RbfA’s 
role in late stage 30S subunit maturation since 30S subunits in strains lacking RbfA contain 
regions of misfolded RNA indicated by exposed nucleotides (Soper et al. 2013). Once RbfA 
completed its goal, RsgA binds and removes RbfA. IF3, an initiation factor, is also able to 
remove or outcompete RbfA from mature ribosomes, highlighting RbfA’s role as a barrier 
between immature and mature 30S subunit and between 30S subunit biogenesis and translation 




Chapter 2: Twister Ribozyme 
Introduction 
Ribozymes are catalytically active ribonucleic acids whose functions arise from their 
properly folded conformations (reviewed in (Jimenez, Polanco, and Lupták 2015)). A number of 
classes of small self-cleaving ribozymes have been discovered (Jimenez, Polanco, and Lupták 
2015), with a recent addition of the twister ribozyme family (Roth et al. 2014). The twister class 
was identified bioinformatically and its biological function is yet to be uncovered (Roth et al. 
2014). The twister ribozyme family is highly conserved and is dispersed throughout the tree of 
life. It is classified by a secondary fold containing three to four helices, two internal loops and 
one outer loop (Figure 3) (Roth et al. 2014; Liu et al. 2014). Its tertiary fold is created by two 
pseudoknots, T1 and T2 (Figure 3, labelled in orange and blue). These pseudoknots play a role in 
positioning nucleotide G39 to act as a base within the active site, allowing for an in-line attack 
by the 2′ O of U-1 on the adjacent phosphodiester, while the A1 base acts to stabilize and 
protonate the leaving product (Wilson et al. 2016) (Figure 3B). The active site is 
conformationally flexible, reaching the active state after local conformational changes that 
properly set up the inline attack (Gaines, Giese, and York 2019). Because all the crystal 
structures involve a non-reactive nucleotide in the active site, the splayed conformation of the 
phosphate backbone and the in-line attack position of the 2′OH is not observed, the proper 
conformational state of the active site has been difficult to deduce.  Once its tertiary structure has 
formed, twister self-cleaves between the U-1 and A1 nucleotide (nt), resulting in a short 5′ 
cleavage product (6 nt) and a 3′ product containing the majority of the ribozyme (48 nt).  The 





Figure 3: Secondary and tertiary structure of twister ribozyme 
A) The secondary structure of twister ribozyme from Oryza sativa (54 nt), labeled 
using the universal numbering system (Roth et al. 2014; Wilson et al. 2016). The 
three helices that are common within the twister family are labelled P1, P2, and P4. 
The two internal loops are labelled L1 and L2, with the third outer loop labelled L4. 
The two pseudoknots are color coded in orange and blue, and labelled T1 and T2 
respectively. In its proper tertiary fold, the nucleotides in the active site are 
positioned for cleavage between the U and A (bright green), as indicated with a red 
arrow in A. 
B) The crystal structure of Oryza sativa twister ribozyme (PDB: 4OJI) (Liu et al. 




great model system for studying RNA folding, as they can be easily manipulated while 
maintaining high activity in vitro.  
Previous work has focused on the activity of twister ribozymes by studying how cleavage 
and folding rates are dependent on pH and divalent metal ion concentrations (Wilson et al. 2016; 
Gebetsberger and Micura 2017). Because of its ability to detect the dynamics of RNA, single-
molecule Fluorescence Resonance Energy Transfer (smFRET) spectroscopy is a direct way to 
study ribozyme folding and cleavage. This has been previously accomplished by labeling twister 
ribozymes with fluorophores and then following the dynamics of twister ribozyme as it folds and 
unfolds, without undergoing cleavage due to the substitution of a deoxy ribose (Panja et al. 
2017b; Vušurović et al. 2017).  These studies on non-cleavable forms of the RNA highlight the 
structural rearrangements that occur during folding, such as the formation of specific 
pseudoknots and the stabilization of helix P1 (Vušurović et al. 2017).  
Because RNA begins to fold as it is being synthesized, Hua et al. mimicked co-
transcriptional folding of twister ribozyme with a helicase (Hua et al. 2018). The helicase was 
used as a way to over-come the difficulties of using an RNA polymerase for transcription of the 
RNA and mimicked the synthesis of twister ribozyme from the 5′ to 3′ end. This work showed 
the early structural rearrangements that occur while the twister ribozyme tries to reach its energy 
minima. The probability of misfolding was higher during its maiden folding transition, while 
during equilibrium the probability of misfolding decreases (Hua et al. 2018). This suggested a 
“molecular memory” for the twister ribozyme: the probability of misfolding is high for the first 
folding event, due to the mispairing of the secondary structure. However, once the proper 
secondary structure has been achieved, the tertiary structure has a lower probability of 
misfolding. 
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All of the above-mentioned studies suffered from a common challenge that arises from 
studying self-cleaving ribozymes, which is that self-cleavage cannot be controlled. In order to 
prevent the ribozyme from cleaving itself during folding experiments, a 2′ deoxyribose was 
substituted at U-1, rendering the RNA non-reactive. This allows for folding and unfolding, but 
the dynamics of the uncleavable twister may not be representative of the structural 
rearrangements that occur immediately prior to cleavage. It is difficult to predict how sufficient 
these folded states are for the activity of the ribozyme because it is incapable of forming product.  
One way to investigate the dynamics and the resulting product of twister ribozyme 
folding is to use a photo-active chemical group to separate secondary from tertiary fold 
controlling the cleavage of twister ribozyme (reviewed in (Klán et al. 2013)). Photocaged 
compounds have been used previously to study both protein and RNA interactions, by preventing 
them from forming the required interactions (Buck et al. 2007; Panja et al. 2015). Once activated 
with a microsecond exposure to light, isomerization of the protecting group results in loss of the 
arylcarbonylmethyl group and regeneration of the proper RNA base.  
In collaboration with the Greenberg lab, who synthesized a modified photocage which is 
activated by visible light, I prepared a caged Oryza sativa twister ribozyme and used this RNA to 
examine tertiary folding of the cleavable ribozyme in real time. I found that immobilized 
photocaged RNA is activated by a 405 nm laser within 30 milliseconds with spatial precision. I 
demonstrated that it is possible to use a photochemical group in combination with smFRET 
spectroscopy to study the folding and cleavage rate of twister ribozyme. By having both spatial 
and temporal control of RNA dynamics, we can study the connection between folding and 
function in a more relevant biological and kinetic context.  
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Results 
Characterizing the cleavage activity of a fluorescent twister ribozyme  
Previous studies were done using a commercially available internal Cy3 residue, which 
destabilized native structure, raising its midpoint of folding when compared to unlabeled twister 
ribozyme (Panja et al. 2017a; Hua et al. 2018).  In collaboration with the Greenberg lab, twister 
ribozyme with Cy3 attached to 2′ OH of U18 was synthesized, because this attachment of the 
dye was expected to be less disruptive to the RNA structure, as seen by other labs (Vušurović et 
al. 2017).  To measure the self-cleavage activity of the Cy3-labeled twister ribozyme, the RNA 
was incubated at different MgCl2 concentrations (0.02-5 mM) for 1 min at 20 ℃. The RNA 
products were resolved on a 10% denaturing gel. Figure 4A and 4B show that increasing MgCl2 
concentration results in more product after 1 min of reaction, as expected. Because twister 
ribozyme is activated by Mg2+ ions during enzymatic ligation of synthetic RNA fragments, a 
significant fraction of cleaved product (~ 30%) is present in the control lane (Figure 4 A,B). 
When the remaining fraction cleaved versus [Mg2+] was fit to a cooperative folding model, the 
midpoint for populating the active conformation of the ribozyme was 0.19 (±0.065) mM MgCl2, 
three times higher than the 0.065 mM MgCl2 midpoint for self-cleavage of unlabeled twister 
ribozyme (Panja et al. 2017a).  
At 2 mM MgCl2, the fraction of twister ribozyme cleaved within 1 min reached saturation 
(~ 75% cleavage), making it a good condition to study its rate of cleavage. To measure the rate 
of cleavage, twister ribozyme was incubated at 2 mM MgCl2 for a range of times (Figure 4C). 
After 70 seconds, the maximum fraction cleaved (70%) was reached. The fraction of product was 
then fit using a single exponential equation to give an observed rate constant of kobs = 0.06 
(±0.004) s-1 or 3.6 min-1 (Figure 4D). This self-cleavage rate was similar to what others have  
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Figure 4: Self-cleavage of U18-Cy3 labelled twister ribozyme. 
 
A)  A denaturing 10% polyacrylamide gel showing self-cleavage of the extended (SA5) 
twister ribozyme after 1 min in the presence of a range of [MgCl2]. The RNA is labelled 
with Cy3 at U18 2’ OH. 
B)  Fraction of cleaved twister ribozyme as in (A). Results of four repeats were globally fit 
to a Hill equation, with a midpoint ([Mg2+]1/2) of 0.19 ± 0.019 mM MgCl2.  
C) A denaturing 10% gel showing the self-cleavage at different times after adding 2 mM 
MgCl2. Cleavage results in an 86 nucleotide 3′ product. 
D)  Fraction of cleaved product versus time after 2 mM MgCl2 was added to start the self-
cleavage reaction. All four repeats are globally fit to a single exponential rate equation, 
yielding an observed rate constant kobs = 0.06 ± 0.004 s
-1, or 3.6 min-1. 
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reported; env22 twister had a rate of kobs = 2.44 min
-1, and O. sativa kobs = 2.45 min
-1 at pH 7.0 
and kobs = 3.5 min
-1 at pH 8.5 at 10 mM MgCl2 and room temperature (Wilson et al. 2016; Ren et 
al. 2014; Gebetsberger and Micura 2017). 
 The midpoint of cleavage of the 2′ OH labelled twister ribozyme in this study has a lower 
midpoint of folding (0.19 mM MgCl2) than the previously studied internally labeled twister 
ribozyme (1.4 mM MgCl2), but still somewhat perturbing when compared to non-fluorescently 
labelled RNA (0.065 mM MgCl2)  (Panja et al. 2017a). This difference is due to the position of 
the Cy3 fluorophore, since the twister ribozyme used previously had the Cy3 fluorophore 
inserted into the backbone of the RNA between U18 and G17, which led to the destabilization of 
the T2 pseudoknot. Crystal structures show that U18 and A23 interact, resulting in G24 and C25 
bulging out, priming them to form the T2 pseudoknot. The backbone addition of Cy3 interrupts 
the proper positioning for the U18-A23 base pair formation.  I hypothesize that changing the Cy3 
position to the 2′ OH group on the ribose of U18 alleviated the strain induced by the backbone-
linked fluorophore and is therefore a more biologically relevant ribozyme construct to study 
coupling of folding and cleavage activity. 
Detecting the folding and unfolding of twister ribozyme via smFRET 
Although gel-based assays measure the MgCl2 –dependence and rate of cleavage, the 
dynamics of folding are hidden due to cleavage being an indirect measurement of folding. 
Single-molecule fluorescence resonance energy transfer (smFRET) spectroscopy allows us to 
directly look at the conformational dynamics of RNA molecules and draw conclusions about the 
kinetics of twister ribozyme folding and cleavage. To adapt the twister ribozyme for single-
molecule studies, as previously done by our lab, the 3′ end was extended with an SA5 sequence 
which anneals to a DNA containing a biotin at the 5′ end allowing for surface immobilization 
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(Figure 5A) (Panja et al. 2017a; Hua et al. 2018). The DNA oligonucleotide is also labeled with a 
Cy5 acceptor fluorophore at the 3′ end in order to observe FRET from the Cy3 donor fluorophore 
located on U18 of the ribozyme. Once the extended twister RNA was annealed to the Cy5-
labeled, biotinylated DNA oligonucleotide, it was then immobilized on a quartz microscope 
slide, using neutravidin, and passivated with DDS (Hua et al. 2014). Molecules were then 
exposed to either a green (532 nm) or red (633 nm) laser to excite Cy3 (the donor) or Cy5 
(acceptor), respectively. As the molecule folds and unfolds, the distance between the Cy3 and 
Cy5 fluorophores changes, which results in a change in resonance energy transfer. I measure this 
as an anti-correlated change in the fluorescence intensity of Cy5 and Cy3. Detecting molecules 
fold and unfold in the presence of different MgCl2 concentrations will allow me to see how 
MgCl2 changes the folding dynamics and potentially detect new conformations via FRET values 
that arise from different structural changes while twister ribozyme folds.  
In order to look at the folding and unfolding rates under different MgCl2 concentrations, a 
non-cleavable variant of the twister ribozyme was made, containing a deoxyuridine (dU) at U-1. 
This chemical substitution removes the 2′OH of the uridine (rU) which is the nucleophile for the 
self-cleavage reaction. This substitution was used previously to generate crystal structures, and to 
detect the folding and unfolding rates (Figure 5A) (Liu et al. 2014). Each movie recorded the 
dynamics of the dU twister ribozyme over five minutes.  The movies produced trajectories of the 
intensity of the Cy3 and Cy5 fluorophores for single molecules in the field of view. The change 
in FRET efficiency, EFRET, was calculated from these intensities after subtracting the background 
and correcting for cross-talk (Figure 5B).  
From the trajectories, we can see there are two states that are populated, a low FRET state 





Figure 5: Folding dynamics of non-cleavable twister ribozyme in a range of 
MgCl2 concentrations 
 
A) Diagram of single molecule folding experiment using non-cleavable (dU 
–1) twister ribozyme. The extended twister ribozyme with Cy3 attached at 
U18 2′OH was annealed to a DNA oligonucleotide containing Cy5 at the 
3′ end and biotin at the 5′ end, forming the SA5 helix (violet). At different 
MgCl2 concentrations, twister ribozyme remains folded (high FRET state) 
or unfolded (low FRET state) for different lengths of time.  
B) Examples of 5-minute traces recorded for different MgCl2 concentrations 
from 0.01 mM to 2 mM. Cy3 and Cy5 signals are represented by green 
and red respectively, while the calculated FRET value is represented by 
black traces. As MgCl2 concentration increases, the time spent by 
molecules in the high FRET increases.  
C) Population histograms showing the change in the folded and unfolded 
populations with increasing MgCl2 concentration. As MgCl2 increases 
from 0.01 mM to 20 mM, the populations shift towards the high FRET, 
folded state. All histograms were fit to a double Gaussian function. 
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Cy3 and Cy5 dyes are far apart, as has been seen previously for the unfolded secondary structure 
of twister ribozyme (Hua et al. 2018; Panja et al. 2017a). The high FRET state is the result of 
twister ribozyme folding into its tertiary fold, as Cy3 and Cy5 come close together upon 
pseudoknot formation (Figure 5A). As the MgCl2 concentration increases, the dwell time that 
twister ribozyme spends in the folded state increases from ~ 10 s at 0.01 mM MgCl2, to greater 
than 5 min (the duration of the movie) above 2 mM MgCl2, while the lifetime of the unfolded 
state decreases (Figure 5B).  This is to be expected, as Mg2+ stabilizes the compact tertiary fold 
of RNAs, by allowing their negatively charged backbones to come closer together without 
repelling each other (reviewed in (Draper, Grilley, and Soto 2005)). By stabilizing these long-
range interactions, Mg2+ increases the length of time that the molecule spends in the folded state, 
increasing the probability of local rearrangements resulting in a product in ribozymes. 
FRET data from thousands of molecules was used to build population FRET histograms 
containing the states of all the molecules (Figure 5C). The population histograms show a much 
clearer picture of the effect of MgCl2 on the state of twister ribozyme. As MgCl2 is increasing, 
the high FRET, folded population increases while the low FRET, unfolded population decreases. 
There are also no detectable intermediate conformations, indicated by the lack of density in the 
histogram between the low and high FRET peaks. This suggests that folding of twister ribozyme 
can be approximated as a simple two state system, with an unfolded and a folded state, as 
previously reported (Panja et al. 2017a). The lack of intermediates can either be because our time 
resolution of 50 ms is not fast enough to capture the formation of intermediate folds, or because 
these intermediates do not form under these conditions.  
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Rate of folding and unfolding of dU twister ribozyme 
Population histograms are a great way to detect intermediates and understand the folding 
pathway of RNA. However, in order to get the rates of folding and unfolding between states, the 
time duration of the unfolded and the folded state needs to be measured. Time trajectories can be 
used to calculate rate constants for folding and unfolding by measuring the dwell times of the 
unfolded state, representing the folding rate, and the dwell time of the folded state, representing 
the unfolding rate. Instead of performing this operation by hand for hundreds of molecules at 
different conditions, Hidden Markov Modelling fits the FRET trace for each molecule to a 
system with two or more states to generate an idealized trace with transition times between low 
and high FRET states, which are then used to calculate the dwell times.  
I used a two-state HMM to analyze the folding kinetics of the dU twister ribozyme 
(Figure 6A). Increasing the amount of MgCl2 slightly increases the rate of folding (kF), while 
dramatically decreases the rate of unfolding (kU) (Figure 6B). At 0.02 mM MgCl2, the rate of 
unfolding is ~10 times faster than the rate of folding (kU is 0.16 s
-1 and kF is 0.014 s
-1).  
Therefore, the unfolded state dominates the kinetics under this condition. If a molecule does fold, 
it will quickly unfold and remain unfolded because the probability of folding is very low. 
However, at 0.1 mM MgCl2, the rates intersect at 0.022 s
-1. This midpoint can also be visualized 
in the population histograms as an equal amount of area under the curve of each peak (Figure 
5C). As MgCl2 concentration increases, the unfolding rate continues to drop and the folding rate 
dominates, as the molecules continue to remain folded. After 0.2 mM MgCl2, it becomes difficult 
to measure rates of folding or unfolding because the chance of a molecule switching between 
states within the duration of the experiment decreases, as the lifetime of the folded state 




Figure 6: Dependence of folding and unfolding rates on MgCl2 concentration 
for the non-cleavable twister ribozyme. 
 
A) An example of a FRET trace in black, analyzed using hidden Markov 
modeling in red.  
B) Rate constants for folding (kF, black) and unfolding (kU, red) of twister 
ribozyme in different MgCl2 concentrations. Rate constants for folding and 
unfolding were both fit to a modified Hill equation, kobs=[Mg
2+]/(k + 
[Mg2+])+c, where k is the rate constant. As MgCl2 concentration increases, 
the rate of unfolding decreases and the rate of folding increases.  
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events, the molecule selection can skew towards the more active molecules and not the stably 
folded or unfolded molecules within the time frame of the movie. This can explain why the rates 
intersect at 0.1 mM MgCl2, and not 0.16 mM MgCl2, as the slower transitioning molecules are 
not counted. 
Previous data collected on the internally Cy3 labelled dU twister ribozyme also showed 
that the unfolding rate decreases with MgCl2, while the folding rate increases with increasing 
MgCl2 (Panja et al. 2017a). At the lowest MgCl2 (0.5 mM), kU = 2.0 s
-1 and a kF = 0.01 s
-1; these 
rate constants become equal at 0.1 mM MgCl2 with kU = kF = 0.07 s
-1. The rate of unfolding 
decreases dramatically, after being ~200 times larger than the folding rate at 0.5 mM MgCl2, 
while the folding rate increases relatively slower by 7 times. From both of the data sets, 
irrespective of the labeling of the twister ribozyme, increasing MgCl2 destabilizes the unfolded 
state rapidly, and makes the folded state favorable. Similar correlation can be seen in the hairpin 
ribozyme, where with increasing MgCl2, the active docked state of the ribozyme is more 
favorable, and the undocked state less favorable (Tan et al. 2003). The rate of switching also 
decreases with MgCl2, as the hairpin ribozyme remains docked at high MgCl2 concentration. 
Although the MgCl2 does not play a role in the reaction, it does stabilize the active conformation, 
just as seen in the twister ribozyme. 
Effect of MnCl2 and PEG8000 on twister ribozyme folding 
 Twister ribozyme is able to fold and self-cleave in the presence of different divalent 
metals. Mg2+ is the second most prominent ion in the cell, behind K+, and is known to support 
RNA and rRNA folding in the cell (Draper, Grilley, and Soto 2005).  However, it was found that 
twister ribozyme has a lower midpoint of cleavage in the presence of transition metal ions such as 
Mn2+ and Ni2+, which has the lowest midpoint of catalysis (Panja et al. 2017a). In order to test 
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the effect of MnCl2 on folding, I titrated the dU twister ribozyme with MnCl2 (Figure 7A). Just 
as with MgCl2, the folded population increases with MnCl2, however, the midpoint of folding is 
0.064 ± 0.0040 mM, two and a half times less than the folding midpoint in MgCl2 (0.16 ± 0.021 
mM) (Figure 7C). This decrease in the midpoint of folding highlights the ability of Mn2+ to 
stabilize the folded state at a lower concentration (Figure 7C). The Hill constant is also larger for 
MnCl2 (n = 1.6). This larger cooperativity of folding also indicated that the folded state is more 
stable in MnCl2, compared to MgCl2 (n = 1.1) which folds noncooperatively.  
Divalent metal ions are not the only cellular components which support the folding of 
RNA. Molecular crowding agents, such as PEG8000, are known to favor the folded, or 
condensed, structures in both RNA and proteins (Kilburn et al. 2010; Dupuis, Holmstrom, and 
Nesbitt 2014). With the cell itself being a crowded environment, molecular crowders are helpful 
in simulating cellular conditions in which an RNA would natively fold. To see the effect of 
crowders on twister ribozyme folding, the twister RNA was titrated with MgCl2 in the presence 
of 10% PEG8000 (Figure 7B). At 0.02 mM MgCl2 in the presence of PEG8000, there is a higher 
population of folded molecules (28% folded) compared to MgCl2 only (6.2% folded) (Figure 
7B). The midpoint of folding in the presence of 10% PEG8000 drops to 0.087 ± 0.029 mM 
MgCl2 (Figure 7C). The most prominent effect is that PEG8000 supports more molecules folded 
under lower MgCl2 concentrations, but has little effect at higher concentrations, as the folded 
population is similar with (75% folded) and without (74% folded) the crowder present (Figure 
7C). This could mean that the rate of folding is influenced the most by crowders when there is 
less Mg2+ present, as the excluded volume effect is supporting more of the folded state (Kilburn 
et al. 2010). However, when MgCl2 concentration increases, the effect of the divalent ion 
overshadows the crowders contribution to folding. Due to this, the Hill constant drops to 0.67, as  
 29 
  
Figure 7: The effects of MnCl2 and PEG8000 on twister ribozyme folding 
 
A) Population histograms of non-cleavable (dU) twister ribozyme under a range of MnCl2 
concentrations. As the concentration of MnCl2 increases, the amount of folded (high 
FRET) twister ribozyme increases more steeply than in MgCl2. Each histogram is fit to a 
double Gaussian function. 
B) Population histograms of non-cleavable (dU) twister ribozyme under a range of MgCl2 
concentrations in the presence of 10% PEG8000. A larger fraction of twister molecules is 
folded in lower MgCl2 concentrations in the presence of PEG than in the absence of PEG. 
Each histogram is fit to a double Gaussian function. 
C) Fraction of folded non-cleavable twister ribozyme as a function of [Mg2+], [Mg2+] with 
10% PEG8000, and [Mn2+].  All three curves are fit to the Hill equation. The midpoints of 
folding of twister ribozyme are 0.16 ± 0.021 mM MgCl2 with n = 1.1 ± 0.15, 0.087 ± 
0.029 mM MgCl2 in 10% PEG8000 with n = 0.69 ± 0.12, and 0.064 ± 0.0040 mM MnCl2 
with n = 1.6 ± 0.15. 
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MgCl2 is contributing less to the stability of the tertiary structure due to the effect of PEG8000 at 
lower MgCl2 concentrations. 
 My data support a model in which different metal ions and crowders support the tertiary 
fold of twister to a higher extent than MgCl2 alone. Crowders can affect folding by collapsing the 
molecules together, which would increase the probability of the pseudoknots forming. However, 
it’s still unknown why Mn2+ and other metal ions are preferred over Mg2+. Neither component 
seems to be stabilizing any distinct intermediate conformation with an intermediate FRET that 
can be detected with my choice of fluorophores (Figure 7A,B). What I can deduce from these 
experiments is that MnCl2 influences both the folding and unfolding rate at low and high 
concentration, while PEG8000 has the most influence at lower concentration of metal ions where 
it destabilizes the unfolded state (Kilburn et al. 2010).  
rU twister ribozyme remains folded once it is cleaved 
 Testing the non-cleavable twister ribozyme is important to deduce the rates of folding 
and unfolding under different concentrations of MgCl2. However, I wanted to look at the 
dynamics of rU twister ribozyme which can self-cleave. To characterize the folding dynamics 
after cleavage, the wild type rU ribozyme was first pre-incubated in 20 mM MgCl2 to make sure 
all of the twister ribozyme had been cleaved. In the presence of 2 mM MgCl2, after being 
cleaved in 20 mM MgCl2, the majority of the population was in the folded state, with very few 
molecules remaining in the unfolded state (Figure 8). In order to test the stability of this fold, the 
cleaved twister ribozyme was challenged with 5 mM EDTA to sequester any MgCl2 in the 
reaction that might support the tertiary interactions. To my surprise, the majority of the 
population stayed in the folded, high FRET state as indicated in Figure 8. Even in 50 mM EDTA, 





Figure 8: Twister ribozyme remains folded once it is cleaved. 
 
Wild type (cleavable) twister ribozyme was allowed to self-cleave, and then imaged in the 
presence of 2 mM MgCl2, 5 mM EDTA, and 50 mM EDTA. The majority of the population was 
in the folded state, irrespective of the effective MgCl2 concentration. 
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population of unfolded or intermediate species that were present, suggesting perhaps that free 
MgCl2 was stabilizing the low FRET state observed in 2 mM MgCl2 and 5 mM EDTA (Figure 
8). The increased EDTA also did not change the FRET value observed of the folded state. The 
FRET value remained close to 0.9, showing that the folded structure remained the same. If there  
was a change, it was not being observed due to the positioning of the fluorophores. The effect of 
EDTA on the folded structure also highlights that the twister ribozyme undergoes a structural 
rearrangement which permits it to remain in the high FRET conformation. It is possible that the 
was a change, it was not being observed due to the positioning of the fluorophores. The effect of 
EDTA on the folded structure also highlights that the twister ribozyme undergoes a structural 
rearrangement which permits it to remain in the high FRET conformation. It is possible that the 
monovalent potassium present in the buffer (100 mM) also supports the folded state in the 
presence of EDTA. Stabilization of the folded state of the cleaved twister ribozyme had been 
reported previously for the env22  twister variant (Vušurović et al. 2017).  
Generating a photoactivatable twister ribozyme  
Studying the dynamics of wildtype twister is difficult due to its fast folding and self-
cleavage. Previously, controlling the tertiary fold was done by flowing in MgCl2 during the 
experiment, with folding driven by the presence of divalent ions (Panja et al. 2017b; Hua et al. 
2018; Vušurović et al. 2017). However, this method is difficult, inconsistent, time consuming, 
and requires a large amount of RNA. Flow in experiments also require 1-2 seconds of deadtime 
for equilibrations, as new components are being flown in. In order to overcome these obstacles, 
the twister ribozyme was made into a photoactivatable RNA, which can start its cleavage process 
in the presence of light. The photocage on the RNA confines the molecule in the unfolded state 
by blocking the formation of pseudoknot T2, until it is activated by light.  
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Previously published data have shown that a mutation of G24 destabilizes pseudoknot 
T2, resulting in a majority of molecules remaining in the unfolded state at high MgCl2 (Panja et 
al. 2017a) (Figure 3). Mutation of G42 within pseudoknot T1 has a similar effect, leaving most 
of twister ribozymes unfolded (Figure 3A). A protecting group that blocks base pairing at these  
positions would allow the photocage to behave as a “conditional mutation”, by disrupting one of 
the pseudoknots from forming Watson-Crick base pairs until deprotected by light.  
In collaboration with Huabing Sun, I synthesized the photo-caged, extended twister 
ribozyme by ligating synthetic oligonucleotides with the desired chemical modifications (Figure 
9).  Due to the inefficiency of coupling a photocaged ribonucleotide phosphoramidite in the 
 middle of a synthesized RNA, it was decided to divide the twister sequence into two fragments, 
with the photocage attached to G24 near the 3 end of the second fragment. Because the RNA 
with photocaged G24 did not react with light as expected (see below), we prepared a second 
RNA in which the photocage was kept at pseudoknot T2 but was attached to G7, located on the 
opposite side of the pseudoknot (Figure 9). This modification blocks formation of the T2 
pseudoknot and therefore prevents the cleavage of twister ribozyme. 
Activation of the photocage attached to twister ribozyme in bulk 
 This newly synthesized photocaged RNA is based on previously established p-
hydroxylphenacyl group (Klán et al. 2013), with a modification which allows it to be activated 
by blue light with a wavelength of 405 nm (Figure 10A). The chemically modified guanosine 
with the protecting group at O6 was chemically synthesized by Huabing. Although the guanosine 
monomer was deprotected by 405 nm light, it was still unknown if it would be deprotected when 
incorporated into a larger RNA molecule. Twister ribozyme with the photocage attached at G7 
(G7PC), was exposed to 405 nm light in solution (Figure 10B) in a light box containing blue  
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Figure 9: Preparation of twister ribozyme U18Cy3 G7PC by ligation 
A) Schematic of the ligation process of twister U18Cy3 G7PC. RNA1 was synthesized in 
house with the photocage and labelled with Cy3 dye. It was ligated to phosphorylated 
(yellow star) RNA2 to make the 28 nt long 5′Ost RNA. Then it was annealed to the 64 nt 
3′ Ost RNA-DNA hybrid containing the rest of the twister ribozyme sequence (RNA) and 
the SA5 sequence (DNA).  
B) Gel purification of 28 nt 5′Ost, product of the first ligation. Bands resolved on a 16% 
denaturing gel. Above 28 nt are multiple ligation products. Band below is a contaminant. 
C) The ligated product was resolved on a 10% denaturing gel, next to WT twister RNA that 




Figure 10: Photocaged guanosine allows rapid ribozyme activation with 405 nm light 
 
A) Chemical structure of photocaged (PC) guanosine being activated by 405 nm light 
(blue arrow) and the final keto form of non-photocaged guanosine. 
B) Secondary structure of Oryza sativa (rice), with stem P1, P2, and P4, and two 
internal loops, L1, L2 and an outer loop, L4. Cy3 is attached to the 2′ OH of U18. 
The photocage protecting group (PC) is attached to the C6 carbonyl of G7. The 
orange and blue nucleotides form pseudoknots T1 and T2, which are necessary for 
self-cleavage between U-1 and A1 in green, as indicated by the red arrow.  
C) Photocaged twister self-cleaves only after activation with 405 nm light. Twister 
RNA in bulk was exposed to 405 nm light for 0-5 minutes, then incubated with 20 
mM MgCl2 for 1 min and quenched with denaturing dye (7M Urea + 50 mM 
EDTA). The samples were resolved on a 10% denaturing gel and scanned for Cy3 
intensity. Two species were detected, the full length (FL) twister-SA5 RNA, 92 nt 
long, and the self-cleaved 3′ product (3′P) 86 nt long. After 5 minutes of blue light 
exposure, 30% of the RNA was converted to 3′ product.   
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LEDs. Without being exposed to blue light, there was no cleavage product in the control without 
MgCl2, and in the 0 min time point with 20 mM MgCl2 (Figure 10C). However, with increased 
time of exposure to blue light, the product increased in the presence of MgCl2. The amount of 
cleaved twister ribozyme increased from zero, to 30% after 5 min of exposure. This shows that  
the photocage prevents cleavage and can be activated by 405 nm light as part of a larger RNA, 
even with diffuse light which does not penetrate the interior of the tubes and liquid effectively.  
Photocage can be effectively activated by 405 nm light in single molecule experiments 
 The benefits of using this newly designed photocage are its ability to be activated by light 
within the visible spectrum, microsecond response times, it is scarless when activated (it 
produces the proper keto tautomer of guanosine) and gives temporal control of RNA folding. 
Because the gel-based assay required a five-minute exposure to reach 30% cleavage, this created 
doubt about whether it would be quickly activated. However, the photocage was tested in 
smFRET experiments with the idea that the poor yield is due to the diffuse, non-specific 
activation that occurs within a light box. To confirm that the photocage did not interfere with 
folding after activation, G7PC-dU twister ribozyme was used to perform analogous smFRET 
experiments as with the non-photocaged dU twister ribozyme. Before activation with 405 nm 
light, most of the molecules remained in the unfolded state (Figure 11B). However, once the 
molecules were exposed to 405 nm light for 0.25 seconds, a large population of molecules 
attained the folded state as evidenced by the appearance of bright Cy5 spots in the FRET channel 
(Figure 11B). Notably, focused activation by the 405 nm laser confined the uncaging reaction to 
defined fields of view (FOV) thereby allowing for imaging of multiple fields of view in a single 








Figure 11:  Photocage enables efficient RNA activation during smFRET experiments 
A) Twister is annealed to an oligonucleotide (SA5) containing Cy5 at the 5′ and biotin 
at the 3′ end, which tethers twister to the quartz slide via neutravidin in purple. In the 
presence of MgCl2 the photocaged G (PC, red octagon) obstructs the formation of 
pseudoknot T2 (blue), resulting in a stable low FRET signal. At high MgCl2, twister 
ribozyme can transiently sample the folded state. After the photocage is activated by 
405 nm light, twister ribozyme is able to test the folded state, and eventually self-
cleave, forming a persistent high FRET product.  
B) The photocage is activated only within the currently observed field of view 
(FOV), ~75 µm × 37 µm. Each FOV, diagramed by red circles on a single channel 
within the slide chamber, was exposed three times to 405 nm light (0.25 s each). 
Without any blue light exposure, there are very few bright spots in the Cy5 channel 
with the green laser on. After 0.25 sec of exposure to blue light, depicted with a blue 
arrow, molecules become bright as they fold into a high FRET state.  
C) At 2 mM MgCl2, photocaged twister RNA remains in its unfolded, low FRET state. 
After 0.25 sec of 405 nm light exposure, ~56% of molecules go into their high 
FRET, folded state. 
D) Most molecules are uncaged after the first exposure to 405 nm light. Further blue 
light exposure does not increase the number of folded molecules. dU twister 
molecules were exposed for 250 ms to 405 nm and rU twister molecules were 
exposed for 30 ms. 
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activation of the photocage specifically by quick exposure to 405 nm light, resulting in a scarless 
RNA.  
Next, I wanted to quantify the population of molecules which fold after activation by blue 
light. Molecules from multiple FOVs were recorded before 405 nm exposure, and then 
molecules were recorded after 405 nm exposure. Even in 2 mM MgCl2 or higher, at the point 
which the non-photocaged dU twister ribozyme plateaued in the folded state, the photocaged  
molecules remained in the unfolded state, with virtually no tertiary folded molecules (Figure 
11C). After 0.25 s of 405 nm exposure, a large population of folded molecules appeared. About 
56% of the molecules folded, while in the non-photocaged dU twister ribozyme tested 
previously, 74% of the population was folded. This discrepancy in the amount of folded 
population may represent a small fraction of photocaged molecules that cannot be activated by 
light. To test the response of the photocage to increasing amounts of 405 nm light, multiple fields 
of views were exposed to blue light, three times each. The largest percentage of the photocage 
molecules are activated by the first exposure to 405 nm, with 56% of molecules folding. Upon 
another 0.25 s exposure of the same FOV, there was a modest increase in the folded population 
(up to 69%) which did not increase further with additional exposures (Figure 11D). A similar 
method was used with the self-cleaving rU twister ribozyme, but each exposure was for 0.03 s 
(Figure 11D). The rU twister ribozyme showed a suppressed response, with the major folding 
event occurring after the first 405 nm exposure, with 40% of the molecules folded, and remained 
steady with subsequent activations. This shows that the photocage can be activated by a single, 
rapid exposure of 0.03 s to light. The inability of a larger population of rU twister ribozyme to 
fold after activation is not due to the quick exposure to light, but instead is due to the structural 
variation in the RNA as will be discussed later.   
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Although not all the molecules are activated by 405 nm exposure, the population 
histograms highlight that the unfolded structure is equal to the structure observed in the non-
photocaged dU twister ribozyme, and the folded state after photocage activation is also equal to 
the folded state of the dU twister and rU twister ribozymes. The photocage is able to “cage” the 
proper secondary fold of twister and allow for the proper tertiary fold after it is activated. In the 
presence of the photocage, the molecules are in the unfolded low FRET state (~0.1), then after 
activation, the molecules are able to organize into the tertiary folded, high FRET state (~0.9), 
and then go on to self-cleave while in the high FRET state (Figure 11A). Non-photocaged rU 
twister experiments have shown that once the RNA is cleaved, it is represented by a persistent 
high FRET state (Figure 8).  
Detecting the folding dynamics of photocaged rU twister ribozyme 
 After verifying the activation of the photocage by blue light and folding of twister 
ribozyme into the proper tertiary fold, the dynamics of folding and cleavage of the photocaged 
rU twister ribozyme was analyzed. Five-minute movies were recorded at different MgCl2 
concentrations within the transition range fraction folded, and the ribozyme behavior before and 
after 405 nm exposure was compared. Within the initial 52.5 s of the movies for MgCl2 
concentrations up to 2 mM MgCl, all molecules remain in a static low FRET state indicating that 
they are unfolded due to the photocage (Figure 12A). In 100 mM MgCl2, the molecules rapidly 
test the folded state in the presence of the photocage but cannot remain stably folded due to the 
presence of the photocage inhibiting formation of one of the pseudoknots.  
Twister ribozyme samples the folded state before cleavage occurs at low Mg concentrations 
 Following activation, the photocaged rU twister ribozyme undergoes transitions from the 
low to high FRET states. These transitions often lead to a persistent high FRET state lasting ≥ 30 
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s which does not transition back to the low FRET state within the duration of the experiment 
(Figure 12A). I interpret the persistent high FRET to represent a cleavage event, since the 
cleaved twister ribozyme exhibits a long-lived static high FRET state (Figure 8). Other labs have 
also reported that the tertiary fold is stabilized after cleavage in twister ribozymes from a 
different species (Vušurović et al. 2017). When compared to the photocaged dU twister 
ribozyme, it becomes clearer that these persistent high FRET states are the result of cleavage 
(Figure 13A). The dU twister ribozyme does not remain in the folded state; it transitions between 









Figure 12: Light activation of twister ribozyme reveals the coupling between folding and 
self-cleavage 
 
A) Sample trajectories of rU twister under different MgCl2 concentrations. Red and green 
traces represent the Cy5 and Cy3 signal respectively, and the black trace represents the 
calculated FRET. Blue line represents time of 405 nm exposure for 0.25 s. Red and green 
boxes at the top represents the sequence of lasers, 10 frames of red at the start and end of 
the movie, and green laser in the middle. 
B) Population histograms of rU twister before and after 405 nm light exposure in a range of 
MgCl2 concentrations.  
C) MgCl2 dependent folding of the different twister variants tested. The high FRET 
population, ƒN, was fit to a Hill equation, ƒF = [Mg
2+]n/([Mg2+]1/2
n + [Mg2+]n), in which 
[Mg2+]1/2 is the midpoint and n is the gradient, ∂ƒN/∂[Mg
2+].  dU twister without the 
photocage has a midpoint of 0.16 ± 0.024 mM MgCl2; dU twister with the photocage 
(dU-PC) after activation has a midpoint of 0.21 ± 0.084 mM MgCl2; rU twister with 






Figure 13: Activation of photocaged non-cleavable (dU) twister ribozyme. 
 
A) Sample trajectories under different MgCl2 concentrations of non-cleavable (dU) 
photocaged twister ribozyme. Just as in figure 12A, red and green traces represent the 
Cy5 and Cy3 signal intensity, respectively, and the black trace represents the calculated 
FRET efficiency.  
B) Population histograms of non-cleavable twister ribozyme before and after 405 nm light 
exposure in a range of MgCl2 concentrations.  
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At low MgCl2 concentrations, twister ribozyme is more likely to fold and unfold multiple 
times, before attaining the persistent fold, highlighting how twister can transiently fold without 
self-cleaving as previously reported (Panja et al. 2017b). At 100 mM MgCl2, twister ribozyme 
folds into its persistent state within a few seconds after the photocage is activated by 405 nm 
light, showing that RNA in higher concentration of MgCl2 are less likely to unfold due to their 
low rate of unfolding, and go straight into tertiary fold and self-cleavage.   
Interestingly, at 100 mM MgCl2, there appears to be a population with intermediate 
FRET. This FRET species is present with and without the photocage, but slightly decreases after 
405 nm light exposure. It is possible that these represent new intermediate structures which are 
only sampled in high concentrations of MgCl2. However, upon inspection of individual 
trajectories, it appears that the lifetimes of the intermediate states are very short, often only 
lasting a single frame. Furthermore, molecules that sample the intermediate states after activation 
with the 405 nm laser never fold into the stable high FRET state. This behavior is more 
consistent with molecules which have not been uncaged.  
 The midpoint of folding of the photocaged rU twister ribozyme is 0.37 ± 0.056 mM 
MgCl2, with a Hill constant of 1 (Figure 12C). A large fraction of the rU variant did not respond 
to 405 nm light or were damaged and cannot adopt its tertiary fold. Instead of plateauing at 83% 
folded, as the non-photocaged dU twister ribozyme, it plateaued at 54% folded (Figure 12C). 
The same behavior can be observed in the photocaged dU twister ribozyme, which plateaued at 
55% folded, but with a midpoint of 0.21 ± 0.084 mM MgCl2 and a Hill constant of 1 (Figure 
12B).  The non-photocaged dU twister ribozyme has a midpoint of 0.16 ± 0.024 mM MgCl2 and 
a Hill constant of 1, similar to the midpoint of cleavage seen in the gel based assay of 0.19 mM 
MgCl2, and the photocaged dU twister ribozyme (Figure 12C). Although the photocage works in 
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a population of molecules, there is a second population that does not respond to activation or is 
damaged. 
Rate of ribozyme folding and cleavage under different MgCl2 concentrations 
 By measuring the rate of folding following photocage activation, I can ascertain the 
kinetics of the first folding events and characterize how folding is coupled with cleavage. To do 
this, I measured the rate of initial folding as the time spent in the unfolded state between 
photocage activation and the first folding event. Similarly, the rate of cleavage was measured as 
the time before the persistent high FRET state which is characterized as having a lifetime ≥ 30 s 
(Figure 14A). I specifically focused on molecules which achieved a persistent high FRET state 
within the length of the movie, because I could not differentiate molecules which failed to be 
deprotected from those that did not happen to fold within the duration of the movie. When I 
included all molecules that have at least one folding event in my analysis, the rates of folding 
became independent of MgCl2 concentration, something that does not match what is seen in gel-
based assays and single molecule folding rates. This MgCl2 independence is due to a population 
of molecules not being activated by blue light exposure.  
 For the active (uncaged) molecules, I find that as MgCl2 concentration increases, the rate 
of initial folding also increases, suggesting that the higher divalent ion concentration is 
stabilizing the folded state (Figure 14B). Similarly, the rate of cleavage increases with increasing 
MgCl2 (Figure 14C). Interestingly, the average time until self-cleavage approaches the average 
first folding time at 0.5 mM MgCl2 (Figure 14 C,D). This is consistent with the initial event 
becoming the cleavage event, as the delay between photocage activation and cleavage becomes 
shorter as observed at very high MgCl2 concentrations, as seen in100 mM (Figure 12A).  
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Figure 14: Folding conditions modulate ribozyme efficiency 
 
A) An example trajectory from a photocaged rU twister showing the time of photocage 
activation with a blue vertical line. The initial folding time is defined as the interval 
from the end of 405 nm exposure to the start of the initial folding event. The time to 
cleavage is defined from the end of 405 nm exposure and the beginning of the 
persistent high FRET state, which represents the product complex. 
B) The frequency distribution for the time to first folding event in 0.1, 0.2 and 0.5 mM 
MgCl2. The cumulative distribution was fit to a single-phase exponential rate 
equation with a burst phase.  
C) The frequency distribution of cleavage time, as in B.  
D) Time to the initial folding event in 0.036 mM MgCl2 + 10% PEG8000 and MnCl2. 
0.036 mM MgCl2 + 10% PEG8000 is isostable with 0.1 mM MgCl2, while 0.05 mM 
and 0.15 mM MnCl2 are isostable with 0.1 and 0.5 mM MgCl2 respectively.  
E) Time to self-cleavage in PEG and MnCl2 as in D. 
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Effect of MnCl2 and PEG8000 on twister ribozyme folding 
 In order to understand the effects of MnCl2 and PEG8000 on the initial folding rate and 
cleavage rate, isostable conditions for each variable were used. The isostable conditions were 
defined as the concentrations of MnCl2 or PEG8000 under which the fractions of folded 
molecules are equal to those in MgCl2. The fraction of folded dU twister ribozyme in 0.05 mM 
and 0.15 mM MnCl2 matched that in 0.1 mM and 0.5 mM MgCl2, while 0.032 MgCl2 was used 
in the presence of 10% PEG8000 this yielded a similar fraction of folded RNA as 0.1 mM MgCl2 
(Figure 7C). The initial folding rate was similar between all three isostable conditions (Figure 14 
D). All the conditions which match 0.1 mM MgCl2 (0.05 mM MnCl2 and 0.032 MgCl2 + 10% 
PEG8000) have similar average times for the initial folding event (40 s), as well as a similar rate 
of folding (0.025 s-1). However, the rate of cleavage is higher in the presence of both MnCl2 and 
PEG8000 relative to the rate of cleavage in MgCl2. When compared to a higher 0.5 mM MgCl2 
concentration, 0.15 mM MnCl2 cleavage rate equals that of MgCl2 at ~0.028 mM. The initial 
folding rate is unchanged between the different conditions, however, the cleavage rate increases 
for MnCl2 at low concentrations but evens out at higher concentrations, explaining how Mn2+ 
preferentially stabilized the folded state of the dU twister ribozyme (Figure 7A,C). At higher 
concentration, MgCl2 is able to compensate for misfolding, that MnCl2 is able to do at lower 
concentrations. 
 I then went on to compare the overall folding rate for all the conditions tested, to see if 
there is any obvious outlier. The overall folding rate looks at all the folding events that occur in 
the lifetime of each molecule (Figure 15). All the conditions provide the expected folding rate, 
with the folding rate increasing with MgCl2 concentrations, and the isostable folding rate being 
close to those of the their MgCl2 counterparts (Table 1). Under equal MgCl2 concentration, the 
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Figure 15: Comparing folding rate to cleavage rate under different ion concertation 
 
The rates of folding and cleavage under different concentration of divalent metal ions. The 
folding rates are in black, while the cleavage rates are in blue. Circle represents MgCl2, square 
represent MnCl2 and open circles are MgCl2 with 10% PEG8000. kobs vs. MgCl2 is fit to a single 
exponential. The folding rates in MnCl2 and MgCl2 plus 10% PEG 8000 are plotted at the 




Table 1: Calculated rates of folding after photocage activation under different isostable 
conditions. 
 
Table 1: Folding 
Rates 
MgCl2 MnCl2 mM 10% 
PEG8000 
[M2+] mM 0.1 0.2 0.5 0.05 0.15 0.036 
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Number of Molecules 86 134 144 136 190 67 
 
Initial fold is the dwell time of the low FRET (~0.1), unfolded molecule, from the time of 
activation with 405 nm light, to the first high FRET (~0.9), folded event. The folding rate is the 
combination of dwell times the twister ribozyme spends in the unfolded state. Folding rate 
without the initial fold, is the time the molecule spends in the unfolded state, without the initial 
high FRET test state. Cleavage is the time between 405 nm light activation and the long-lived 
high FRET state. Errors represent the 95% likelihood confidence interval calculated using 
GraphPad Prism 8.  
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initial folding rate, the overall folding rate, and the folding rate without the initial folding event 
are relatively equal. However, for high MnCl2 concentration, the initial fold happens quicker by 
0.01 s-1. Meaning that once twister ribozyme performs an initial fold, its probability of folding 
again is lower than it was to perform the first fold. While MgCl2 increases the initial folding rate 
and subsequent folding rates equally, MnCl2 seems to increase the initial fold the most, while the 
other general folding rate lags behind, explaining how the cleavage rate could match at higher 
divalent ion concentrations.  
PEG8000 is the opposite, with a slow initial fold (0.025±0.002 s-1), and then quick 
folding rates after (0.043 ±0.003 s-1). PEG8000 seems to stabilize a structure that needs some 
time to attempt to fold, but once it folds and unfolds, its probability of re-folding almost doubles. 
This can explain why PEG8000 has the biggest effect at lower MgCl2 concentrations. At low 
MgCl2 concentrations, the chance of a molecule folding is low for both the initial and subsequent 
folds, 0.021±0.002 and 0.026±0.004 s-1 respectively, however, in PEG8000, the initial fold is 
equals to that of MgCl2 alone (0.021±0.002 s
-1), but its subsequent folding probability jumps 
once it stabilizes the folded, compact state. Therefore, PEG8000 seems to function by 
destabilizing the unfolded state, just as others have seen before (Kilburn et al. 2010).  
Testing activation of the photocage on nucleotide G24 
 The photocage positioned at G7 had proven to be beneficial for understanding the 
dynamics of twister ribozyme. However, I wanted to see if the photocage transferred to a 
secondary position on the same pseudoknot functions similarly to G7PC (Figure 16A). To test 
this, I generated a twister ribozyme containing a photocage on nucleotide G24 which is located 
on the opposite side of the same pseudoknot as G7. G24 stabilizes the T2 photocage but does so 




Figure 16: Activation of G24PC twister ribozyme with blue light 
 
A) Schematic of twister ribozyme G24PC (red octagon), which has the photocage on 
the opposite side of pseudoknot 2.  
B) The activation of the photocage at the G24 nucleotide position. A population has 
folded before exposure to 405 nm light. After 405 nm exposure, the folded 
population increases slightly from 26% to 31%. 
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I found that the G24PC twister ribozyme was still activated by blue light, but it did not 
activate to the same extent as G7PC twister ribozyme in 2 mM MgCl2 (40%) (Figure 16B). It is 
also obvious that the photocage at G24 did not completely prevent folding, with 26% of the 
population already folded before blue light activation. With blue light activation, the folded 
population slightly increased to 31%. This discrepancy between G7PC and G24PC might be due 
to interactions between the photocage and its neighboring nucleotides. I also found that the 
photocage began to respond to the green laser at a wavelength of 532 nm. The response was not 
as fast as to the blue light, requiring seconds of exposure instead of microseconds to activate the 
photocage. During the purification process, the photocaged RNA is scanned for Cy3, meaning 
that it is exposed to a green laser, which could deprotect a population of the RNA, resulting in 
the 26% folded population before blue light activation.  
Discussion 
 Twister ribozyme is a great candidate for RNA folding studies due to its short size and 
availability of crystal structures (Liu et al. 2014; Ren et al. 2014). Furthermore, its activity can be 
modulated using ribozymes that are modified with fluorophores and photocages to better explore 
its dynamics and self-cleavage. I developed a novel tool to successfully control twister ribozyme 
dynamics with photochemistry allowing me to decouple the secondary fold from the tertiary fold 
with a fast activating photocage. This also marks the first attempt at studying a photocaged RNA 
using TIRF microscopy. 
 Initial studies showed that the twister RNA can be modified with a fluorophore without 
disrupting the folded RNA a significant amount. Our lab’s previous attempt to label twister 
ribozyme had proven somewhat flawed, as the fluorophore within the backbone disrupted the 
tertiary fold of twister and required a hundred times higher concentration of MgCl2 to reach the 
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folding midpoint. The rates of cleavage calculated for U18 are similar to those that were 
published previously with related, unlabeled twister ribozymes, showing that the new labeling 
scheme did not disrupt the folded structure. The midpoint of cleavage observed in the gel-based 
cleavage assay (0.19 ± 0.019 mM), nearly matches the midpoint of folding we observed by 
smFRET spectroscopy (0.16 ± 0.021 mM), and is close to what was measured for the photocaged 
dU twister ribozyme (0.21 ± 0.083 mM MgCl2). Compared to the midpoint of folding observed 
previous by Panja et al. using smFRET spectroscopy (15 mM MgCl2) the fluorophore label, as 
well as the photocage, did not significantly disrupt the folding and subsequent cleavage of the 
ribozyme (Panja et al. 2017a).  
 The Greenberg lab, which was responsible for synthesizing the photocage and then 
incorporating it within the RNA, had succeeded in shifting the activation wavelength of the 
photocage into the visible spectrum (405 nm). The experiments discussed here showed that the 
photocage is active when being incorporated into an RNA, responds to 405 nm light, is fast 
activating and does not disrupt the structure of the unfolded or folded states. Our time activation 
limit was 0.03, due to our shutter and camera speed, which is the shortest activation time we 
tested in the smFRET experiments. However, this photocage hypothesized to be removed within 
the μs timescales, which would require different instrumentation to test (Klán et al. 2013). I 
found that this technique could be multiplexed and performed in a high-throughput manner, since 
different fields of view can be activated individually allowing for multiple experiments to be 
performed in the same channel, without needing to do flow-in experiments, as was previously 
required.  
When incorporated on the G7 nucleotide of the twister ribozyme, the photocage 
succeeded in protecting the ribozyme in the unfolded state. Looking at the population 
 55 
histograms, it becomes clear that the photocage is protecting the unfolded state, through a range 
of concentration of MgCl2 (Figure 12B). The unfolded state has the same FRET values as seen 
previously, with the same being true for the folded state, highlighting that the we are looking at 
the same structures that occur without the photocage. Furthermore, the rates of folding observed 
at 0.1 and 0.2 mM MgCl2 in the photocaged rU twister ribozyme (kF = 0.025 ±0.001 and kF = 
0.037 ±0.001) matches the rates of folding of the non-photocaged dU twister ribozyme (kF = 
0.022 ±0.002 and kF = 0.03 ±0.0002). This suggests to us that the structure of the activated 
ribozyme is not affected and the dynamics we witness after photocage activation are biologically 
relevant. 
The rate of the initial fold and the rate of folding match throughout MgCl2 concentrations 
(Table 1). This highlights that the photocage does not disrupt the secondary fold of the twister 
ribozyme, because it does not have a slower rate of folding right after 405 nm light activation. 
The rates are equal between the initial fold and general fold, meaning that the photocage does not 
confine the twister ribozyme into an unproductive structure.  
In the presence of high MgCl2 concentration, the G7PC ribozyme samples the folded 
state (Figure 12B) indicating that this structure may form but is highly unstable when the 
photocage is present. The appearance of these transitions at high MgCl2 concentration could be 
due to Mg-dependent compaction folded state possibly by supporting partial formation of the 
main pseudoknot labeled in orange (Figure 11A). However, due to the photocage, the secondary 
pseudoknot is not available to lock the structure into the folded state, resulting in rapid 
unfolding. The photocaged rU twister ribozyme had a midpoint of folding of 0.37 ± 0.16 mM 
MgCl2, hinting at the disruption of its structure via the photocage. However, I believe this is not 
the case, as its more likely that there is a population of photocaged molecules that are not 
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responding to 405 nm light. At low MgCl2 concentrations, there are a few molecules that fold 
with and without the photocage.  However, as the MgCl2 concentration increases, the fraction of 
folded molecules is being suppressed by molecules which are unable to be activated by 405 nm 
light. The same effect can be seen with the photocaged G24, whose activation by 405 nm light is 
greatly suppressed. There is a large possibility that the photocage interacts with the RNA 
structure, which prevents it from being activated by blue light. This same structure formation can 
also explain how G24 is able to be activated by a 532 nm green laser. Therefore, when designing 
a photocaged RNA, the surrounding nucleotides and structure should be taken into account in 
order to see a proper benefit.  
 Testing the effect on folding rates at different concentrations of MgCl2 within the 
transitional phase allowed me to detect unproductive folding of twister ribozyme, before its final 
cleavage. At low MgCl2 concentrations, there are several folding attempts before persistent 
folding and cleavage is achieved. The number of these initial folding attempts decreases as 
MgCl2 concentration increases. Furthermore, as the concentration of MgCl2 increased, the 
average time until both the initial folding event and cleavage decreases (Figure 15). At some 
point, the initial folding rate and the cleavage rate will intersect as the molecule would fold into 
its persistent high FRET state right after activation. These experiments cannot detect the 
nucleotide level rearrangements that might occur within the active site required for cleavage, 
only the formation of stable pseudoknots can be detected. At lower MgCl2, the active site 
rearrangement might require the molecule to unfold, and refold until it cleaves, stabilizing the 
folded state. However, at high MgCl2 concentration, the rearrangement can be done in the folded 
state, which is stabilized by increased metal ion concentration. Therefore, cleavage might occur 
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later in the lifetime of the folded state but due to our fluorophore positioning, we can only detect 
the persistent state which we consider to be the folded state.   
 It has been well established that twister ribozyme has a lower midpoint of folding in the 
presence of Mn2+ and that PEG8000 increases the population of the folded state at the same 
MgCl2 (Panja et al. 2017a). Testing isostable conditions in the presence of MnCl2 and PEG8000 
was done to understand the reasons for these observations. At first, I hypothesized that these 
conditions will allow me to detect and stabilize intermediates that occur during folding, by 
watching the dynamics at these conditions. However, no stabilized intermediates were detected 
in either MnCl2 or PEG8000 conditions. This is likely due to the time resolution limit of 30 ms. 
Previous labs were able to detect intermediate steps in different ribozymes only after increasing 
their resolution of 10 ms (Tan et al. 2003). I observed that MnCl2 affects the twister ribozyme by 
increasing its initial folding rate, while keeping the general folding rate relatively equal, as the 
MnCl2 concentration is increased. This seems to point to MnCl2 destabilizing the unfolded state 
and favoring formation of the folded state which in turn increases the chances of cleavage. The 
opposite may be true in the presence of 10% PEG8000, where it increases the general rate of 
folding, while keeping the rate of the initial fold low. This explains the effect of PEG8000 at low 
MgCl2 concentrations. The initial rate of folding is slow, once it folds and unfolds, the chances 
of it refolding doubles, resulting in a larger population of folded molecules at lower MgCl2. 
RNA structural formation is critical for function, therefore studying RNA structural 
dynamics and folding rates is instrumental in understanding function. Creating a photo-
activatable self-cleaving ribozyme opens many avenues for the study of RNA folding and 
cleavage under different environmental conditions. By creating a photo-activatable RNA, the 
experimenter becomes the conductor of the RNA, deciding when the RNA should undertake its 
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journey though the folding pathway. Here we develop and test a fast acting photocage on the 
twister ribozyme to better understand its unfolded to folded transition and cleavage.  
Materials and Methods: 
RNA synthesis 
 All RNA sequences were based on the Oryza sativa twister ribozyme, 5’-r(CCGCCUAAC 
ACUGCCAAUGCCGGUCCCAAGCCCGGAUAAAAGUGGAGGGGGCGG), with a 38 nt 
SA5 DNA extension at the 3’ end d(AGGACGACACACTTTGGACAGGACACACAGGAC 
ACAGG), resulting in a 92 nt long Ost Twister-SA5 RNA. All sequences either order through 
Invitrogen, IDT or custom made for this study were gel purified before being used in ligation 
reactions. Variations of Cy3-labeled Ost Twister-SA5 ribozyme were prepared by enzymatic 
ligation of RNA fragments (Table 2) corresponding to the 5 half of twister, 5′- Ost Twister 
r(CCGCCUAACACUGCCAAUG CCGGU2’Cy3CCCA), and the extended 3 half of twister, 
3′Ost Twister-SA5, with the aid of a DNA splint, OSTSplint. Various 5 Ost Twister fragments 
were prepared as follows: The 5′- Ost Twister self-cleaving RNA with a photocage at position 
G7 was made by ligating 5′OST11nt and 5′-3′OstG7PCU18Cy3 using 5'OST-LigSplint. 5′-
3′OstG7PCU18Cy3 was synthesized in-house using standard phosphoramidites, 2'amino-uridyl 
phosphoramidite (Glen Research) for attachment of Cy3, and the custom synthesized photocaged 
G phosphoramidite (GPC) (Huabing Sun).  A photocaged non-self-cleaving variant containing 2′-
dU at position 6 was prepared in the same way using 5'OST11ntdU. The non-cleavable, non-
photocaged twister RNA was prepared by ligation of 5′Ost-dU-U18cy3 and 3′Ost Twister-SA5 
without a splint. G24PC was generated by ligating 3′OstG24PC, with the rest of the SA5_-4 
sequence, suing SA5 splint, to create a photocaged 3′Ost Twister-SA5. Then the 3′Ost G24PC 
Twister-SA5 was ligated to 5′- Ost-cy3, to make the full-length Ost twister ribozyme  
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Table 2: RNA and DNA oligonucleotides used in this study 
 Name Sequence Source 










4 5′OST11nt r(CCGCCUAACAC) IDT 
5 5′-
3′OstG7PCU18Cy3 
r(UGPCCCAAUGCCGGU2’NH2CCCA) this study 
6 5'OST11ntdU r(CCGCC)d(U)r(AACAC) this study 
7 5′Ost-dU-U18cy3 r(CCGCC)d(U)r(AACACUGCCAAUG 
CCGGU2’Cy3CCCA) 
this study 




9 SA5_-4 d(GACACACTTTGGACAGGACACACAGGAC 
ACAGG) 
Invitrogen 




All RNA oligonucleotides were gel purified on a denaturing 16% polyacrylamide gel.  
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U18Cy3G24PC. Biotin-SA5-Cy5 was used to anneal to SA5 containing Twister molecules and 
tether them to quartz slides. All procedures involving the photocaged RNA were done in low 
light to prevent the photocage from being activated.  
Fluorophore labeling 
 Before ligation, amine modified RNAs were labelled with sulfonated Cy3 (GE Amersham 
Cy3 or Cy5 Mono-Reactive Dye Packs, catalog number PA23001 and PA25001), respectively. 5 
nmols of RNA was combined with 33 μl of entirely resuspended fluorophore in DMSO and the 
volume brought up to 100 μl with 100 mM NaCO3, pH 8.6 in a dark tube and left overnight at 
room temperature (~20℃). The reaction was then divided into two 50 μl aliquots and passed 
over two CHROMA SPIN+TE10 columns (Takara, cat# 636066) to separate the free dye from 
the RNA. The flow-through from each column was combined and the RNA precipitated with 3 
volumes of ethanol and 15 μg glycogen and incubated at -80 ℃ for one hour. The RNA 
precipitate was collected at 14,000 rpm for 30 min, washed with 70% ethanol, and again spun at 
14,000 rpm for 30 min. The liquid was decanted, and the RNA dried under vacuum in a 
SpeedVac SC100. The RNA was dissolved in 10 μl deionized water (18.2 M, RNase-free) and 
stored at –20 ℃. 
RNA ligation 
 All ligations were done using the method of Stark and Rader with some modifications 
(Stark and Rader 2014). The 3′ RNA (12 μM final) was phosphorylated with 40 U T4 PNK 
(NEB) in the presence of 1.5 mM ATP and 12 U RNasin Plus (Promega) in a total volume of 40 
μl at 37 ℃ for 30 min, and then denatured at 65 ℃ for 10 min (Figure 9). The reaction was 
placed on ice and the 5′ RNA fragment was added, with or without the DNA splint, in the ratio 
of 1:1.2:2 RNA1:Splint:RNA2 (Rodgers et al. 2016). The volume was brought to 46 μl with 
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deionized water and annealed in a thermocycler by heating to 90 ℃ for 2 min and decreasing the 
temperature by 5 ℃ every 2 min, until the temperature reached 5 ℃. The reaction was then 
placed on ice and 20 U T4 RNA ligase 1 (NEB) was added in the presence of 1X ligation buffer 
(NEB) and another addition of 1.5 mM ATP, and incubated 16 hrs at 16 ℃. The RNA products 
were resolved on a denaturing 16% (28 nt RNA) or 10% (92 nt RNA) polyacrylamide gel. The 
bands were scanned for a Cy3 signal on a GE Typhoon, alongside a control RNA of similar in 
length as a size marker. The desired product bands were excised, and the RNA extracted by 
freeze-thaw and soaking for 16 hrs in 1X TE Buffer (10 mM Tris-HCl, pH 7.4, 1 mM EDTA). 
The RNA was then precipitated with 3X volume of ethanol, and spun at 9K RPM, 4 ℃ for 30 
mins. The supernatant was discarded, and the pellet washed with cold 70% ethanol, and again 
spun down at 9K RPM, 4 ℃ for 30 mins. The pellet was then resuspended in 10 μl of deionized 
water. 
Twister activity assays 
 All activity assays were done as previously described (Panja et al. 2017a). A mixture of 40 
nM Ost-Twister and 60 nM of Biotin-SA5 DNA in 1X HK buffer (30 mM K-HEPES, pH 7.5; 
100 mM KCl,) was incubated at 75 ℃ for 5 min, followed by 37 ℃ for 15 min, and 25 ℃ for 5 
min. The mixture was then kept at room temperature and 4 μl were added to PCR tubes 
containing 1 µl 5X MgCl2. After 1 min, the reaction was quenched with 2X TBE urea loading 
buffer (8 M urea, 90 mM Tris-HCl, 89 mM Boric Acid, 0.04% bromophenol blue and xylene 
cyanol, with 50 mM EDTA). To detect the cleavage of Twister over time, the annealed RNA was 
added to 5X MgCl2 (2 mM final) and the reaction was quenched at various times with the 
addition of 2X TBE denaturing loading dye. The reaction products were resolved on a denaturing 
10% polyacrylamide gel for 2 h at 15 W. The gels were scanned for the Cy3 signal (GE 
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Typhoon). The bands were quantified using ImageQuant 5.2, and the relative fraction cleaved 
was plotted in Graphpad Prism 8.   
 In order to check for removal of the photocage protecting group in bulk samples, 2 μl of 
the photocaged Twister mixture mentioned above (2 µl 40 nM twister•biotin-SA5) was exposed 
to 395-405 nm blue LEDs in a custom-made dark box. A motorized sample holder was used to 
rotate the sample as it was exposed for different lengths of time. After each exposure, the tube 
was transferred to a dark container. Then the exposed twister solution was added to tubes 
containing MgCl2 and allowed to react for 1 min at room temperature. The reaction was 
quenched with 2X TBE denaturing loading dye and the products resolved on a denaturing 10% 
polyacrylamide gel for 2 h at 15 W. The gel was scanned and analyzed as described above. 
Single molecule FRET assays 
 In a 10 μl reaction, 40 nM Twister RNA was combined with 20 nM Biotin-SA5-Cy3 DNA 
in 1X HK Buffer with 12 U RNasin Plus. The reaction was incubated at 75 ℃ for 5 min, 37 ℃ 
for 15 min, 25 ℃ for 5 min, and then kept at room temperature. The mixture was diluted 700-
fold in 1X HK buffer and loaded right away onto a covered quartz slide passivated 
with dichlorodimethylsilane (DDS, Sigma, cat# 440272-100ml) 0.2 mg/ml biotin-BSA (Sigma 
cat# A8549-10MG), 2% Tween 20, and 0.2 mg/ml streptavidin as previously described (Hua et 
al. 2014). The slide was incubated with this mixture for 1 min, before the unbound RNA was 
washed away with imaging buffer containing 1X HK buffer, MgCl2 or MnCl2, 0.8% glucose, 4 
mM Trolox, 0.1 mg/mL glucose oxidase and 0.02 mg/mL catalase. Reactions also contained 
10% PEG8000 where stated.  
 The data were acquired using a home built prism-TIRF microscope, composed of an 
Olympus IX73 microscope with an Andor iXon Ultra EMCCD camera, CrystalLaser 405 nm 
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blue laser (19 mW output), 633 nm red laser (19 mW), and a 532 nm green laser (63 mW) (Roy, 
Hohng, and Ha 2008). Intensities in the green and red channels were recorded with 532 nm 
excitation. Each movie started and finished with ten frames of 633 nm excitation to detect the 
presence of the acceptor. All population histograms were built using 40 frame long movies, with 
each frame being 50 ms. At least 10 movies, with more than 200 molecules were used to build 
each histogram. Histograms showing the population after exposure to the 405 nm laser for 250 
ms or 30 ms, were recorded 2 min after exposure to the blue laser, after twister molecules reach 
equilibrium. Long movies involving 50 ms frames were recorded for 1020 frames, or ~ 1 min, 
while movies used for the detection of first folding and cleavage events were taken for ~ 5 min 
with 250 ms frames, with 405 nm laser exposure occurring at 52.5 s for 1 frame.  
Single molecule data analysis 
 Trajectories showing the intensities of single molecules over time were extracted from the 
raw movies using custom IDL code (Hua et al. 2014, 2018). Only molecules that have a Cy5 
signal in the first ten frames of a movie, which were used for direct excitation correction, and 
had a Cy5 and a Cy3 signal within the first twenty seconds, which were used for leakage 
corrections, were selected for further analysis.  
Population histograms 
 Population histograms were generated from a combination of ten movies, split into three 
batches, composed of 40 frames, with the middle 20 frames used to show the state of the 
molecule (FRET state). In making the histograms, molecules were not selected in any way other 
than having both Cy5 and Cy3 active fluorophores. Corrections for the background, reflection, 
leakage and direct excitation were made using the principals published previously (Hellenkamp 
et al. 2018). Histograms of the FRET efficiency were fit to two Gaussian equations (a1*exp(-((x-
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b1)/c1)^2) (MatLab) to calculate the area under the curve for the high FRET state and the low 
FRET state. The ratio of folded molecules to total molecules, ƒF = (area highFRET / area 
highFRET + area lowFRET) was calculated for each third of the data. These three values were 
used to calculate a mean and standard deviation for ƒF at each condition. The change in ƒF with 
divalent metal ion concentration, [M2+], was fit to a Hill equation ƒF = [M
2+]n/([M2+]1/2
n + 
[M2+]n)and the midpoint ([M2+]1/2) of folding and hill constant (h) extracted. MgCl2, MnCl2 or 
PEG8000 concentration versus relative fraction folded were graphed and analyzed using Prism 8 
graphing software. 
Rates of folding and unfolding 
 To get the rate constants of folding or unfolding, 5 min movies of non-cleavable dU twister 
ribozyme were recorded with different MgCl2 concentrations. Each trace was selected by hand, 
throwing out any molecules with quick bleaching event (within the first minute of the movie) or 
missing an active Cy3 or Cy5 fluorophore. The Cy3 and Cy5 intensities were then corrected for 
background, reflection, leakage and direct excitation and traces were selected when the molecule 
had more than one folding or unfolding event. Hidden Markov Modeling was done to get rates of 
folding and unfolding of non-cleavable twister ribozyme as previously described (McKinney, 
Joo, and Ha 2006).  
Rates for initial folding and cleavage 
Custom MatLab codes, as those used above, written and kindly provided by Boyang Hua 
from the Ha lab, were used to sift through 5 min long traces for those which had stable and active 
Cy3 and Cy5 fluorophores, which were selected for further analysis. Traces were analyzed by 
hand and the time from 405 nm laser exposure (52.5 s after the start of the movie) until the first 
folding event and subsequent folding events were analyzed within MatLab by selecting the start 
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and end times of the highFRET state. Start of high FRET was identified as the first instance 
when the Cy5 signal increased, while the Cy3 signal decreases. The time from 405 nm exposure 
to the first folding event was labelled as the initial fold, and the last stable folding event that was 
longer than thirty seconds in the cleavable twister ribozyme is self-cleavage. Molecules that had 
one active fluorophore or fluorophores that bleaches quickly (within less than 1 min of the start 
of recording) were discarded. The molecules were discarded because their quick bleaching 
prevented them from being useful in calculating folding or cleavage rates. For non-cleavable dU 
twister ribozyme, the average times to the initial folding event or to self-cleavage were 
calculated only with molecules which showed at least one folding event (high FRET state) after 
405 nm exposure. For self-cleaving (rU) twister ribozyme, molecules that ended with a persistent 
high FRET state were used to analyze the initial folding rate, general folding rate and cleavage 
rate. A frequency distribution histogram was built of the dwell times for folding and cleavage 
events, and then fitted to a one phase decay equation, to get the rates of initial folding, self-
cleavage and folding rate of the molecule at different MgCl2 concentrations. All rate calculations 




Chapter 3: 30S Subunit Helix 1 Folding 
Introduction: Studying the formation of Alternative Helix 1 
Helix 1 within the 30S ribosomal subunit contains the first nucleotide sequences to be 
synthesized, but it is one of the last to fold. Previous data published has hinted at a possible 
competing structure that forms and refolds later during the maturation of the 30S subunit. This 
refolding event is thought to be done by a ribosomal assembly factor which can bind and 
stabilize helix 1 over the competing helix. In order to test this hypothesis, the formation of the 
competing helix was simulated using two annealed RNAs and challenged with proteins which 
are hypothesized to disrupt it and refold into the native helix 1. Studying this behavior can 
further our understanding of the type of interactions that occur between proteins and RNA, while 
providing more detailed information about the maturation of the 30S subunit.  
Mutation in Helix 1 influences 30S subunit Maturation  
Previous experiments have shown that upstream regions of the 16S rRNA affect 30S 
subunit maturation by acting in a folding catalyst like manner (Balzer and Wagner 1998). 
Mutations in the 16S rRNA itself has also been found to influence the maturation of the 16S 
rRNA. The Noller lab identified a mutation within helix 1 (H1), C23U, which results in cold 
sensitivity, increase in free 30S and 50S subunits, incomplete processing of 17S rRNA, and a 
decrease in the amount of 70S ribosomes.  These are all phenotypes of improperly matured 
ribosomal subunits (Dammel and Noller 1993). This mutation destabilizes H1 by changing a G-C 
Watson and Crick base pair to a G-U (Figure 18), thereby increasing the free energy of H1 and 
making it less likely to form. If H1 does not form, then helix 2 (H2) cannot properly fold, which 
forms the active site for the 30S subunit (Figure 17). The central H2 pseudoknot is positioned at 
the core of the 30S subunit, bringing together both the 5′, central and 3′ domains of 16S rRNA 
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Figure 17: Proteins binding close to the central pseudoknot (Helix2) 
  
 The central pseudoknot brings together the 5′ domain in light blue, central domain in 
purple and 3′domain in light pink (PDB: 4V7S) (Dunkle et al. 2010). The disruption of base 
pairing due to the C23U mutation in helix 1 is highlighted in orange. Ribosomal proteins which 
bind close to the central pseudoknot and helix 1 are shown. S4 in red, signifying it’s a primary 
binding protein, while S5 and S12 are different shades of green signifying they are secondary 
binding proteins. Mutations in S5 have cold-sensitive phenotypes linked with delayed 30S 
maturation. Protein S12 is a late assembly protein, and was identified as an interacting partner 
for Hfq, which is proposed to be a 30S assembly factor. S4 nucleates the folding of the 5′ domain 
and interacts with H1 in the mature 30S ribosome. 
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together (Figure 2). By disrupting or slowing down the formation of H2, the translation ability of 
the 30S subunit becomes disrupted (Brink, Verbeet, and Boer 1993; Poot et al. 1998).  
Making compensatory mutations can rescue the cold sensitivity of the C23U mutation 
(Dammel and Noller 1993). Mutating G11A, rescued the Watson-Crick base pairing within H1, 
making H1 more favorable (Figure 18). The Noller lab also identified a mutation in the 5′LS, C-
5U, that rescues the cold sensitivity of C23U. With this revelation, it was hypothesized that parts 
of the 5′LS make contact with 16S rRNA during folding, and a potential alternative-helix 1 (alt-
H1) could form during maturation. Mutating C-5U destabilizes the hypothesized Alt-H1, making 
H1 more favorable in the C23U mutation. Overexpression of the assembly factor RbfA was also 
found to rescue the C23U phenotype suggesting that binding of RbfA may help overcome 
destabilization of H1 by C23U (Dammel and Noller 1995). RbfA is thought to bind in the late 
stages in maturation and promote processing of 17S to 16S rRNA, but the mechanism for how 
RbfA aids in maturation is not clear. These genetic studies suggest RbfA may function during 
formation of H1, H2, and the central pseudoknot perhaps by binding directly to H1 and 
stabilizing it (Figure 18). Although multiple labs have tried to visualize pre-30S particles using 
X-ray crystallography, electron microscopy, and footprinting, none have been able to identify the 
position of the 5′LS and the hypothesized alt-H1 (Yang et al. 2014). It is not known concretely if 
alt-H1 is capable of forming, where it would be located on the pre-30S, which parts of the 5′LS 
participate in the folding of 30S subunits, and what is the switch that signals the 5′LS to move 
from its chaperone function for cleavage. I want to detect the switching between alt-H1 and H1, 
and understand the molecular mechanism which plays a role in the switching of the helices. 




Figure 18: Competition between Alt-H1 and H1 
 
It is hypothesized that part of the 5′LS, in red, makes an ALT-H1 (top left) by binding to the 5′ 
domain of 16S, in blue, sequestering the necessary nucleotides that form H1 (top right). 
Performing modeling calculations, it can be seen that the Alt-H1 has a lower free energy than 
H1, making more stable than H1. Making mutations that disrupt H1 (C23U), makes H1 less 
likely to form. However, compensatory mutations, such as G11A and could rescue H1 by 
restoring Watson-Crick base pairing (Dammel and Noller 1993). Cold-sensitivity can also be 
rescue by C-5U mutation which disrupts Alt-H1, making Alt-H1 unfavorable. Overexpression of 
the assembly factor RbfA (in pink), was found to rescue the cold-sensitive phenotype of the 
C23U mutant (Dammel and Noller 1995). It is hypothesized that RbfA is able to stabilize H1, 
allowing for RNase G, in orange, to come in and cleave the single-stranded RNA. This results in 
stabilizing H1 and the central pseudoknot at the late stages of 30S maturation. Figure derived 




5′LS forms a complex with 16S in trans  
 To study the competition between helix 1 and alternative helix 1 (alt-H1), I simulated alt-
H1 formation by forming a complex in trans between native 16S rRNA and either the full length 
5′LS (115 nts) or truncated 5′LS variants (Table 3). Initially, I used native gel mobility shift 
assays to resolve bound 5LS•16S complexes from free 5LS. The 115 nt WT 5′LS is capable of 
binding to the 16S rRNA at 42 ℃ and after a 65 ℃ incubation (Figure 19A, B). Because more 
5LS•16S complexes were present after 65 ℃ incubation, that was the temperature used for all 
the follow up experiments.  Using 15 nt short 5′LS oligonucleotides, which are just long enough 
to form the predicted alt-H1 without any extra upstream sequence, I tested their ability to bind to 
16S rRNA and form the alt-H1. I generated two mutant 5′LS oligonucleotides that are predicted 
to form more or less stable alt-H1 interactions. The ‘ideal’ mutant 5′LS oligonucleotide contains 
a U-3C mutation which converts a G-U wobble into a G-C base pair, creating a more stable alt-
H1 helix (Table 3). I observed that both the WT and ideal 5′LS oligonucleotides could form a 
complex with the 16S rRNA. I also tested the C-5U mutation (labeled ‘mutant’ in Figure 19) that 
was previously identified by the Noller lab to disrupt alt-H1. This mutant 5′LS oligomer is 
unable to form a complex with the 16S RNA, suggesting that stable base-pairing is required for 
binding of the 5′LS to 16S RNA (Figure 19A, B) (Dammel and Noller 1993). These data suggest 
that the complex formed between the WT 5′LS and the 16S rRNA likely contains alt-H1 and is 
sequence specific.  
In order to perform fluorescence anisotropy experiments, to detect the formation of the 
5LS•16S, fluorophore (FAM) labelled oligos were created. Although the anisotropy experiments 
did not take off, the FAM labelled sequences provided cleaner data for the native gel mobility  
 71 
Table 3: 5′LS variants tested for trans binding to 16S 






WT GAGCGUCAAACUUUU 15 
Ideal GAGCGUCAAACUCUU 15 






FAM-Ideal UUUGAGCGUCAAACUCUU/3AmMO/ 18 
FAM-WT UUUGAGCGUCAAACUUUU/3AmMO/ 18 
FAM-Mutant UUUGAGCGUCAAAUUCUU/3AmMO/ 18 
 
Names and sequences of the different variants of the 5′LS used for intermolecular binding to 16S 
rRNA. The mutations are labelled in red. All the short oligos were received from IDT. 5′LS was 
transcribed from amplified PCR products and then labelled with 32P. While FAM-5′LS was made 





Figure 19: Binding of 5′ leader to 16S rRNA 
 
A) The binding of 32P-labelled 5′LS and its variants to 16S rRNA. 5′LS and its variants are 
colored in red, while 16S rRNA is black with blue dots representing G-U wobble base 
pairs. 5′LS, full-length 115 nt leader and WT, oligonucleotide that corresponds to the last 
15 nt of the leader, both bind to the 16S rRNA. The fully matched (U–3C) Ideal 
oligonucleotide is also able to bind the 16S rRNA, but the Mutant (U–5C) 
oligonucleotide does not bind 16S rRNA. Top schematic shows how RNA samples were 
annealed before loading on the gel. 
B) Similar to A, except that the oligonucleotides are labelled with a 6-FAM fluorophore. 
Once again, the Ideal and WT binding whereas the U-5C Mutant does not bind the 16S 
rRNA. The binding between 5′LS and 16S rRNA is sequence dependent. 
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shift assays. I repeated these gel shift binding experiments with fluorophore labeled 
oligonucleotides to confirm the results obtained with radiolabeled RNAs (Figure 19B).  
 Mature 30S subunits cannot bind 5′LS 
 Since the 5′LS binds to native 16S rRNA, I wanted to see if this would hold true for 
mature 30S subunits. Because the 30S subunit is matured, the central pseudoknot and H1 are 
folded, and r-proteins are bound to the rRNA preventing H1 from unfolding. I combined the 
5′LS RNA with 30S subunits and incubated the mixture at 42℃, the same temperature used for 
30S reconstitution, or at 65℃, knowing that the higher temperature would denature some of the 
r-proteins. 5′LS RNA cannot bind to mature 30S subunits (Figure 20A, lane 7), showing that H1 
is stably folded and cannot be converted to Alt-H1 in the presence of the r-proteins. However, if 
the 30S subunit is denatured at high temperatures, 5′LS can bind to the partially denatured 16S 
rRNA (Figure 20A, lane 8). Because 5′LS clearly binds to naked RNA, I hypothesized that a 
rearrangement of the 16S rRNA during 30S subunit assembly unwinds alt-H1 and releases the 
5′LS. To test whether such a rearrangement occurs during 30S subunit assembly, I aimed to 
reconstitute 30S subunits from the 5′LS•16S complex. 
5′LS is removed during 30S subunit reconstitution  
After seeing that these RNA-RNA complexes can form, I challenged them with different 
components, ranging from r-proteins to assembly factors, to test how binding of different factors 
influenced the stability of 5LS•16S RNA complex. I formed 5LS•16S rRNA complexes with 
labeled 5′LS oligonucleotides at 65℃ for 15 min and then incubated the complexes with TP30 at 
various concentrations at 42℃ for 15 min. Upon incubation of TP30 with 5LS•16S rRNA 
complexes, a super shift can be observed in the native gel after 15 min suggesting that proteins 
from TP30 can bind to 5LS•16S RNA complexes (Figure 20A). At higher concentrations of  
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Figure 20: Binding of ribosomal proteins to 5′LS•16S rRNA complex. 
 
A) Native gel resolving the 5LS•16S complexes containing alt-H1. After annealing the 
complexes at 65 ℃, they were incubated with increasing concentration of total proteins 
of 30S (TP30) at 42 ℃. The diagram above the gel highlights the steps performed for this 
experiment. In the two right most lanes, mature 30S is probed for 5LS binding at 
different temperatures. 
B) Native gel showing the presence of Alt-H1 complex in the absence (16S) or presence of 
TP30 (1:4 of 16S:TP30) over time. Using a 1:4 ratio of 16S rRNA to TP30, alt-H1 
disappears when compared to no TP30. This result would suggest that having TP30 is 
good enough to refold alt-H1 to H1. The diagram above the gel highlights the steps 
performed for this experiment. 
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TP30 relative to 16S RNA, the complexes migrate slower indicating further protein 
binding until the bands disappear completely at the highest concentration of TP30 (512 nM; 
Figure 20A). The absence of signal for the 5LS•16S RNA complex suggests that alt-H1 has 
been unwound. 30S subunit reconstitution requires 60 min of incubation at 42 ℃ and I found 
that the 5′LS remains bound to 16S for the entirety of my time course without TP30. I then 
performed a time course to test if TP30 requires the full 60 min to remove the 5′LS and found 
that TP30 disrupts the binding in <5 min (Figure 20B).  
A new method for detecting 5′LS rearrangement  
Native gel mobility shift assays are great for visualizing interactions in non-denaturing 
conditions. However, for these experiments, I came across a reproducibility issue, where on 
some days I would see the removal of the 5′LS from the rRNA while on others I would not. I 
also saw a difference to the extent 5′LS is removed or stabilized on the 16S rRNA. Therefore, I 
decided to design a new method for examining 30S subunit reconstitution and 5′LS removal 
using a pelleting assay system (Figure 21A). In this assay, I first form the 5′LS•16S RNA 
complex in the same manner as for the native gel assays. Following formation of the 5′LS•16S 
RNA complex, TP30 was added and incubated for 60 min followed by pelleting the sample 
mixture over a 40% sucrose cushion, which separates large components from small components. 
All the unbound proteins and RNA that are not heavy enough are removed in the supernatant, 
while only the heavy complexes are left behind in the pellet. Following the sucrose cushion, I 
resolve the samples using SDS-PAGE to detect the presence of proteins and RNAs within the 
pelleted complexes. Therefore, using this assay I can measure the 5′LS signal disappearance as a 
function of 30S subunit reconstitution. Instead of running native samples, I am able to resolve 
the presence of the 5′LS in denaturing conditions which would prevent interference from  
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Figure 21: Pelleting assay to detect the reorganization of 5′LS•16S rRNA complex by TP30 
 
A) Schematic outlining the pelleting assay. 16S rRNA and 5′LS are mixed and incubated at 
two temperatures, then combined with TP30 and incubated for 30 min to allow for 
reconstitution to occur. Some reconstituted mixture is kept as “input” to be loaded on an 
SDS-PAGE and a urea denaturing gel, while the rest is loaded on to a 40% sucrose 
cushion. Large reconstituted complexes pellet, so the sucrose can be discarded, and the 
pellet is then resuspended and loaded on an SDS-PAGE and 10% denaturing gel. 
B) An example of an SDS-PAGE gel resolving the proteins present in the pellet on the top 
and a 10% denaturing gel to resolve RNA on the bottom. Input sample that is loaded on 
the sucrose is on the left, while the pellet is on the right. TP30 by itself, sample 1 and 2, 
does not pellet, but 16S rRNA with 5′LS does. Adding an increasing concentration of 
TP30 decreases the amount of 5′LS present, as the alt-H1 is being switched to H1. 
C) Increasing TP30 concentration decreases the amount of 5′LS that pellets with 16S rRNA. 
This is based on four separate repeats. 
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structured rRNAs and proteins. This assay also allows me to examine which proteins are present 
in the pelleting complexes, which was not possible in the native gel assay. I am also able to 
compare what was loaded on the sucrose cushion to what pelleted by running the “input” sample 
and “pellet” sample on the same gel. 
Using the pelleting assay, I found that the 5′LS can only pellet when it is bound to 16S 
rRNA (Figure 22; Lane 1), and TP30 proteins also pellet in the presence of 16S rRNA, showing 
that 30S subunit reconstitution is occurring (Figure 21B; lane 4-6). TP30 alone cannot pellet over 
a sucrose cushion because the individual proteins are not heavy enough, resulting in the removal 
of proteins as can be seen when comparing SDS-PAGE gel between the input and pellet (Figure 
21B). Increasing TP30 concentration results in more 30S subunit complexes pelleting, and less 
5′LS being bound (Figure 21C). The pelleting assay shows that alt-H1 can be switched to H1 in 
the presence of only r-proteins and suggests that removal of the 5′LS is likely dependent on some 
degree of 30S subunit reconstitution. In figure 2, I highlighted three possible proteins in TP30 
which might play a role in H1 formation, with S4 and S5 being the most likely candidates. 
Mutations within r-proteins, such as S5 which binds close to the 5′ of 16S, also resulted in cold 
sensitivity very similar to the C23U mutants and affects the translation capability of the ribosome 
(Nashimoto et al. 1971; Roy-Chaudhuri, Kirthi, and Culver 2010). Although S4 is one of the first 
r-proteins to bind, we know the final bound structure of S4 does not occur until further r-
proteins, such as S16, bind later in maturation (Abeysirigunawardena and Woodson 2015). The 
late stage restructuring of S4 and binding of S5, and their close positions to H1, make them the 






Figure 22: 30S does not bind 5′LS 
 
Sample #5 shows that the 5′LS cannot bind to mature 30S subunits. All the TP30 proteins are 
present in the 30S sample. However, if 30S rRNA is heated to 65 ℃ and the r-proteins are 
denatured, 5′LS is able to bind as seen in sample #6. There are some missing r-proteins that did 




Specific proteins may be required for alt-H1 to H1 transition 
 As previously seen in native gels, the pelleting assay verified that 5′LS cannot bind to 
mature 30S subunits (Figure 22; lane 5). This is consistent with the observation that the central 
pseudoknot present in mature 30S subunit is very stable (Poot et al. 1998). Upon denaturation of 
30S subunits at 65℃, I find that 5′LS can now be seen in the pellet, indicating that the 5′LS has 
bound to 30S subunits (Figure 22; lane 6). These data suggest that alt-H1 cannot be formed 
unless the complex is denatured under high heat (~ 65℃). My data also shows that denaturing 
the 30S subunit at 65℃ does not fully denature the complex, since some proteins remain bound 
to 16S rRNA. This suggests that high temperature removes the proteins that are required for 
keeping H1 folded, and this can help us identify the proteins responsible for alt-H1 to H1 
switching.  
RbfA’s role in alt-H1 to H1 transition  
RbfAs ability to rescue the cold sensitive phenotype of 16S rRNA C23U mutation made 
it a primary candidate for testing its ability to switch alt-H1 to H1. When RbfA is added with 
TP30 to the 16S rRNA and 5′LS complex, it does not remove more 5′LS than just TP30 alone 
(Figure 23A; lane 4-6, 9B). This shows that RbfA might not play a direct role in the helix 
switching that occurs during maturation. The r-proteins are mainly responsible for removing 
5′LS and switching alt-H1 to H1. The removal of 5′LS by TP30 is also temperature dependent 
(Figure 23 C,D). Just like 30S subunit in vitro reconstitution requires 42℃, removal of the leader 
did as well. This highlights that the 16S rRNA and TP30 are reconstituting and removing the 
5′LS, switching alt-H1 to H1 as was hypothesized. Keeping the reaction at room temperature did 




Figure 23: RbfA does not affect the 5′LS•16S rRNA complex and 42 ℃ is required for 
removal of 5LS 
 
A) Gel showing the pelleting of TP30, RbfA, and 5′LS after reconstitution. RbfA, TP30, and 
5′LS do not pellet together without the presence of 16S rRNA. Because RbfA is similar 
in size to other r-proteins, it is difficult to resolve the RbfA band on a 1D SDS-PAGE.  
B) TP30 removes 5′LS from 16S rRNA, as seen previously. However, adding 1:1 or 1:2 
ratio of 16S:RbfA does not increase the amount of 5′LS removed as was predicted. The 
amount of 5′LS present with and without RbfA is similar. This is based on three repeats. 
C) The removal of 5′LS by TP30 is temperature dependent. Under higher temperature of 
42℃, TP30 is removing the 5′LS. At the same temperature, in vitro 30S reconstitution is 
done, signaling that we are getting reconstituted particles.  
D) TP30 at room temperature (RT) does not remove the 5′LS. 30S reconstitution in vitro 
does not occur at RT, therefore alt-H1 is not switched to H1. Reconstitution 30S subunits 




Reconstitution is hindered by heat treatment of native 16S rRNA 
 The pelleting assay was a great way to lower any noise I was detecting on the gel and 
purify the complexes I was interested in from unbound proteins and RNA. However, I continued 
to suffer from reproducibility issues, and I tested different temperatures, buffer components for 
reconstitution, native 16S and TP30 purification and handling, 5′LS variations, but changing all 
the components in the reaction did not improve the reproducibility issue.  
I looked closer at the reconstitution reaction itself that I was performing by doing 
ultracentrifugation over a 10%-40% sucrose gradient (M. Nomura 1968). I found that the 16S 
rRNA can reconstitute into mature 30S subunit in the presence of 5′LS at 42℃ (Figure 24). 
However, if native 16S rRNA is incubated at 65℃ with the 5′LS, it can no longer reconstitute 
into 30S subunits. This may explain the variation I was seeing. In order to get as much 5′LS 
bound, I typically incubated the 16S rRNA at 65℃ with the 5′LS. Although 5′LS can bind to 16S 
rRNA at 42℃, the signal in my gels were weak indicating that some 16S RNA could not bind 
the 5′LS unless it was denatured. By incubating the RNAs at high temperature, I was denaturing 
the structure that was present in the purified native 16S rRNA. Once the rRNA was denatured, it 
was unable to be refolded into a reconstitution-competent conformation. Although other people 
have shown that in vitro transcribed 16S rRNA can reconstitute into 30S particles, the 
reconstitution is inefficient and other intermediates can be found (Figure 25). By denaturing the 
16S rRNA I was getting varied results because I would end up with different populations of 30S 
particles every experiment due to having so many different components present in my reactions 






Figure 24: Reconstituting 30S ribosomes after 16S rRNA denaturation in the presence 
of 5′LS 
 
A 10%-40% sucrose gradient showing the position of 16S rRNA and 30S subunit after 
reconstitution in the presence of 5′LS. Native 16S rRNA was pre incubated at 42℃ (red) or 
65℃ (black) with 5′LS, then TP30 was added at 42℃ and the standard protocol for 30S 
reconstitution was followed. The peaks were then resolved with a fractionator. The blue line 
represents a mixture of 16S rRNA and 30S subunit as a control to establish the position of 
the peaks. After 42℃ incubation and in the presence of the 5LS, 30S particles can be 





Figure 25: Reconstitution of in vitro transcribed 16S 
 
A 10%-40% sucrose gradient showing the position of 16S rRNA and 30S subunit after 
reconstitution. The blue line represents a mixture of native 16S and 30S that was done as a 
control to detect the position of the two peaks. The red line is reconstituted 30S from native 
16S. The black line is in vitro transcribed 16S and it runs at the same position as native 16S. 
The purple line represents 30S reconstitution with in vitro transcribed 16S. Although a large 
amount of 30S particles do get reconstituted, there is a long tail stretching from the 16S peak 
which highlights the variation in reconstituting in vitro 16S. 
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Hfq plays a role in 30S subunit biogenesis 
 Host Factor for replication of bacteriophage Qb (Hfq) is a hexameric RNA chaperone 
that has a regulatory role in bacteria (Santiago-Frangos and Woodson 2018). Its ability to 
catalyze the binding of different mRNAs and sRNAs makes it an important regulator of 
transcription and stability of varied RNAs. Parts of the 5′LS have sequence similarities to sRNAs 
which bind Hfq (A rich patches), suggesting that Hfq might play a role in the maturation of 30S 
subunits. To test this hypothesis, I performed binding assays between Hfq and the 5′LS (Figure 
26). I found that Hfq binds the 5′LS tightly and their interactions are comparable to those of 
identified Hfq sRNA substrates (Figure 26A). I then tested mutant Hfq65 which is missing its 
regulatory C-terminal tails and found that it binds 5′LS as well, but not as tightly as the WT 
(Figure 26B) (Santiago-Frangos et al. 2016). Hfq65 Y25D which has a mutation on the face of 
the protein which binds poly-A sequences, is still able to bind the 5′LS, suggesting that this is not 
the binding site of the 5′LS (Link, Valentin-Hansen, and Brennana 2009). The Hfq65 K31A 
mutants, which is located on the same face as Y25, bound the 5′LS as well but had less higher 
order complexes which represent multiple Hfq proteins bound to the 5′LS. 
 A few months after these experiments were done, a paper was published showing that an 
Hfq deletion strain has a similar phenotype to an RbfA deletion. The Hfq deletion strain was cold 
sensitive, had a decrease in 70S ribosomes, and an increase in 30S and 50S subunits. The 
deletion strain was also prone to mistranslation in the presence of antibiotics, and footprinting 
results showed a difference in probing at the 5′ helix 1. This suggests that Hfq might play a role 
in the switching of alt-H1 to H1 during the late stages of maturation, and the stabilization of the 
central pseudoknot. Although my data suggest that r-proteins are required for 5′LS removal, Hfq 
may catalyze this process, just as other assembly factors but is not a requirement. It has also been  
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Figure 26: Hfq binds to the 5′LS 
 
A) Native gels showing titration of Hfq proteins to a constant concentration of the 5′LS. Hfq 
binds the 5′LS efficiently, and the size of bands begin to increase as multiple Hfq proteins 
bind to the RNA. 
B) Native gel comparing the binding of the C-terminus deletion mutant Hfq65, Hfq65 
Y25D, and Hfq65 K31A. 5′LS can still bind Hfq, but there are less higher order 
complexes with multiple Hfqs, as is expected. Y25D does not seem to affect Hfq binding, 
except increasing the amount of higher order complexes compared to Hfq65. K31A can 
weakly bind the 5′LS but does not form higher order complexes, just like Hfq65. 
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found that Hfq stimulates RNase E dependent degradation of RNA, which might hint at the 
possibility of Hfq recruiting RNase E to cleave the 5′LS (Santiago-Frangos and Woodson 2018; 
I.M. Sharma, Korman, and Woodson 2018). 
Conclusion and future directions 
 The synthesis and maturation of the ribosome and its ribosomal subunits is a complex 
process which the cell spends the majority of its energy on (Williamson 2006). Due to its 
complexity, it is difficult to study and isolate all the different variables that play a role in these 
processes. I had difficulty in reproducing my experiments because of the complexity involved in 
30S subunit folding. Keeping all 21 r-proteins, assembly factors, and two RNAs active proved to 
be difficult at the same buffer conditions and through an hour of incubation and an overnight 
ultracentrifugation spin.  
Although reproducibility was an issue, there are still some take away points that I have 
learned. The 5′LS does bind to the 16S rRNA, and it does so in a sequence dependent manner. 
The same mutation (C-5U) that rescues the cold sensitivity in C23U mutants, also prevents 5′LS 
from binding to 16S, showing that the structure formed between the two RNAs likely forms in 
trans in vitro. Denaturing native 16S rRNA makes it difficult to reconstitute with TP30, just like 
it is difficult to reconstitute 30S subunit from in vitro transcribed 16S. The purified 16S already 
has some structure that remains even after the purification step. Although TP30 dependent 
removal of 5′LS was inconsistent, there have been multiple instances in which TP30 did remove 
the 5′LS from 16S. In order to get a better idea of what is going on, different TP30 purifications 
should be analyzed with mass spectrometry in order to see if the current purification method is 
consistent and gives us the full a stochiometric amount of 21 r-proteins every time. There is a 
potential for some TP30 preparations to have less S4, S5 and S12, all candidates that might help 
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H1 fold (Figure 17). The 5′LS cannot bind to mature 30S subunit but can bind to denatured 30S 
subunit. This shows that the proteins that come off during denaturation are responsible for 
keeping the central pseudoknot folded and preventing alt-H1 from forming. A mass spectrometry 
analysis of mature 30S subunit and denatured 30S subunit would eliminate some r-proteins that 
do not play a role in central pseudoknot stability. Figure 22 shows that there are still proteins 
bound to denatured 30S subunit and it will be interesting to identify them. When the removal of 
5′LS RNA works, it is temperature dependent, and occurs at the same temperature as 30S subunit 
reconstitution. This tells us that protein and RNA interactions do occur, and a different structure 
is being stabilized over the competing 5′LS and 16S rRNA structure.  
My results suggest that RbfA does not play a role in the altH1/H1 transition, however, 
further experiments are required to confirm this. Hfq binds to the 5′LS, interacts with RNase E 
and S12, all components which exist around the central pseudoknot in pre-30S complexes, 
making Hfq a contender for participating in the alt-H1 to H1 conversion (Figure 17) (Strader et 
al. 2013; I.M. Sharma, Korman, and Woodson 2018). 
These are difficult experiments, but progress can still be made. In our lab, we established 
and optimized a protocol to purify pre-30S particles. Because these particles contain 17S rRNA, 
we can purify and probe the structure using footprinting to measure the position of the 5′LS. We 
could also perform cryo-EM on either the pre-30S particle alone or as part of the 70S complex. 
We know that pre-30S can go into the translational pool of ribosomes, so it would be interesting 
to see how the 5′LS is positioned in these complexes (Indra Mani Sharma and Woodson 2019; 
Soper et al. 2013).  We can also try performing reconstitution experiments using natively 
purified pre-30S complexes. I was unable to get in vitro reconstitution of 17S rRNA to work 
efficiently and knowing that native 16S purifies with a somewhat already folded structure, it 
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might be easier to reconstitute pre-30S particles from native pre-17S. The reconstitution of native 
17S with TP30 purified from pre-30S and 30S subunit can help us understand the differences 
between the pre-30S and 30S complexes. We can also fluorescently label the 5′LS of native 17S 
and watch its processing as more reconstitution components are added. The experiments 
proposed above would help us increase our understanding which proteins are responsible for alt-
H1 to H1 switching and would allow us to visualize the processing for pre-30S into mature 30S 
subunits. 
Materials and Methods 
30S subunit purification 
The 30S subunit purification protocol was adopted from previously published protocols 
(Nierhaus 1990). MRE600 cells were grown in LB media at 37 ℃, then at OD600 =1, kept at 4 ℃ 
for one hour to break 70S ribosomes into the 30S and 50S subunits. The cells were then pelleted, 
lysed through emulsification by Emulsiflex Homogenizer and debris cleared. Lysate was then 
loaded on to a 40% sucrose cushion containing buffer D (1.1 M Sucrose, 20 mM Tris-HCl, pH 
7.5, 500 mM NH4Cl, 10 mM MgCl2 and 0.5 mM EDTA). To purify large complexes (30S, 50S, 
70S), the lysate was spun in a Ti 60 rotor, O/N at 40K RPM, 16 hrs, 4 ℃ in the UltraCentrifuge. 
The next day the supernatant decanted, and the pellet washed with buffer B (20 mM Tris-HCl, 
pH 7.5, 20 mM NH4Cl, 0.5 mM MgCl2, 0.5 mM EDTA, and 6 mM β-Me) to get rid of the brown 
layer on the translucent pellet. The pellet was then resuspended in 500 μl buffer C (50 mM Tris-
HCl, pH 7.5, 1.5 mM NH4Cl, 5 mM MgCl2, and 6 mM β-Me) by shaking on ice for 3 hrs. The 
resuspended pellet was then dialyzed twice into buffer E (50 mM Tris-HCl, pH 7.5, 150 mM 
NH4Cl, 1 mM MgCl2, and 6 mM β-Me) for 30 min each, 60 min total. The solution was then 
loaded on to a 10%-40% sucrose gradient containing buffer E. To separate 30S subunits from 
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50S subunits and 70S ribosomes, the mixture was spun in a SW 28 rotor for 16 hrs, at 25K RPM, 
4 ℃. The 30S subunits were then separated from the rest using a fractionator, and elution peak 
detected via A260. In order to concentrate the 30S subunit, it was spun again in Ti60 rotor on a 
40% cushion with buffer D at 40K RPM, 4 ℃, 16hrs. The supernatant was decanted and 
resuspended in Buffer A (20 mM Tris-HCl, pH 7.5, 20 mM NH4Cl, 10 mM MgCl2, 0.5 mM 
EDTA, and 6 mM β-Me) over 3 hrs while shaking. The 30S subunit was then aliquoted and 
frozen.  
16S purification 
The 16S purification protocol was adopted from previously published protocols 
(Nierhaus 1990). Buffer containing 20 mM HEPES pH 7.6, 0.5 mM MgCl2, 300 mM NH4Cl, 1 
mM Spermidine, 0.1 mM Spermine, 6 mM β-Me and 1% SDS was combined with 250 μl of 30S 
subunit and volume brought up to 500 with npH2O. After mixing, equal volume of phenol was 
added and vortexed at 15 min in the cold room. The aqueous layer was separated from the 
organic layer with a 13K RPM spin for 10 minutes. The aqueous layer was separated once again 
and phenol was added a second time. After this second separation, chloroform was added to the 
aqueous layer, and again separated in the same way as previously. Then 1.25 μl of 0.5 M EDTA, 
50 μl of 3M CH₃COONa and 3x EtOH (~1.7 ml) was added and kept overnight in -80 ℃. The 
precipitated RNA was spun down at 9K RPM for 30 min, at 4 ℃. A 70% EtOH wash was 
performed and then the pellet was dried in a speed-vac. The dried pellet was then resuspended in 
300 μl TE Buffer and stored at -80 ℃. 
TP30 purification 
 The TP30 purification protocol was adopted from previously published protocols 
(Nierhaus 1990). Buffer containing 20 mM HEPES pH 7.6, 8 mM MgCl2, 600 mM NH4Cl, 2 
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mM Spermidine, 0.2 mM Spermine, 10 mM β-Me, was combined with 250 μl of 30S subunit and 
volume brought up to 500 with npH2O. 100 μl of 1M magnesium acetate was added, followed by 
2.2 ml of acetic acid. The solution was rocked at 4 ℃ for 1 hr, then centrifuges at 9K RPM for 
30 min. 16.5 ml of acetone was added, mixed, and stored in -80 ℃ overnight. The precipitated 
proteins were then spun at 9K RPM for 30 min, and the pellet resuspended in 1ml of 7M urea, 20 
mM Tris-HCl, pH 7.5, 20 mM MgCl2, 150 mM KCl, and 6 mM β-Me. The proteins were then 
dialyzed in the same buffer overnight. The next day the proteins were dialyzed into a non-urea 
containing buffer (20 mM Tris-HCl, pH 7.5, 20 mM MgCl2, 150 mM KCl, and 6 mM β-Me) for 
90 min. The concentration was measured at A230. 
Native gel mobility shift assays 
 The 5′LS•16S RNA complex was formed by combining 100 nM of 5′LS and 128 nM of 
16S rRNA in 30S subunit reconstitution buffer (80 mM K-HEPES (pH 7.6, 300 mM KCl, 20 
mM MgCl2, 6 mM β-Me and 0.01% (w/v) Nikkol detergent), with a final volume of 10 μl. The 
mixture was then incubated at 65 ℃ for 15 min, followed by 42 ℃ for 15 min. To challenge the 
complex, 256 nM of TP30 was added, mixed, and kept at 42 ℃ for another 1 hr. 10 μl of the 
mixture is then loaded on a native gel. Resolving the 5′LS•16S RNA complex on the same gel as 
free 5′LS required making a two layered gel. The bottom layer was a 16% TBE native gel, while 
the top layer was a 4% TBE gel. The gel was pre-ran for 30 min at 15 W, and then the complexes 
resolved for two hours at 15 W. Experiments that were done with radio-labelled RNA were then 
dried and exposed overnight, while those with fluorescently labelled RNA were scanned for the 
fluorophore on a GE typhoon. 
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Pelleting assays 
 As with the native gel mobility assay, The 5′LS•16S RNA complex was formed by 
combining 100 nM of 5′LS and 128 nM of 16S rRNA in 30S subunit reconstitution buffer (80 
mM K-HEPES (pH 7.6, 300 mM KCl, 20 mM MgCl2, 6 mM β-Me and 0.01% (w/v) Nikkol 
detergent). The mixture was then incubated at 65 ℃ for 15 min, followed by 42 ℃ for 15 min. 
To challenge the complex, 256 nM of TP30 was added, mixed, and kept at 42 ℃ for another 1 
hr. 10 μl of the mixture is then removed as the input, and stored at 4 ℃ overnight, while the 
other 90 μl were loaded on a 40% sucrose cushion. The mixture was then spun in a SW-50 Rotor 
at 40K RPM for 16 hours at 4 °C. The pellet was then resuspended in 20 μl of 30S subunit 
reconstitution buffer. 5 μl of the input and 10 μl of pellet were mixed with equal amount of SDS-
Buffer, and then resolved on a 4%-10% SDS-PAGE and then resolved on a 4%-10% SDS-
PAGE. While 5 μl of the input and 10 μl of pellet were mixed with equal amount of 2X 
denaturing dye (7M Urea, 1X TBE, 0.2% Bromophenol Blue, 0.2 % Xylene Cyanol dye) and 
then resolved on a 10% denaturing gel. The gels were then imaged after staining or scanned for 
FAM labelled on the GE typhoon. 
30S subunit in vitro reconstitution 
 The 30S subunit purification protocol was adopted from previously published protocols 
(M. Nomura 1968; Masayasu Nomura and Held 1974; Nierhaus 1990; Culver and Noller 1999), 
and the additions made in our lab.  Natively purified 16S rRNA was incubated in 30S subunit 
reconstitution buffer (80 mM K-HEPES, pH 7.6, 300 mM KCl, 20 mM MgCl2, 6 mM β-Me, and 
0.01% (w/v) Nikkol) for 15 min at 42 °C. Then TP30 was added at a ratio of 1:2 of 16S rRNA: 
TP30 and incubated for 1 hour at 42 °C. The mixture was then loaded on a 10%-40% sucrose 
gradient buffer (20 mM K-HEPES, pH 7.6, 330 mM KCl, 20 mM MgCl2) and spun in the SW41 
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rotor, for 15.5 hours, at 32K RPM and 4 °C. The presence of 16S rRNA and 30S subunits were 
detected using a fractionator and a UV monitor which detected absorbance at A260. The UV 
monitor was hooked up to a program which detect the signal, which was then exported and 
plotted in GraphPad Prism 8.  




Chapter 4: Ribosomopathies 
Introduction  
Ribosomes, molecular machines which are responsible for protein synthesis in all living 
cells, are indispensable for the proper function and development of a cell. Composed of ribosomal 
RNA (rRNA) and ribosomal proteins (r-proteins), ribosomes synthesize new proteins using 
messenger RNAs (mRNAs) as blueprints. Proper protein synthesis is essential for cell growth and 
division. Cells which lack functional ribosomes are unable to perform proper protein synthesis, 
and therefore undergo growth arrest until the issue is fixed, or undergo cell death. When cells 
function as one part of a whole, improper protein synthesis can result in improper growth and 
disease in the whole or the organism. Ribosomopathies are disorders which arises from improper 
ribosome biogenesis, the pathway for ribosome maturation from rRNA and proteins to a 
functioning complex in the cell.  
 Previously it was believed that ribosome biogenesis is an uncompromising aspect of cell 
growth and development. If a mutation were to occur in any gene that participates in ribosome 
biogenesis, it was believed to be lethal because proper ribosome biogenesis is crucial for ribosome 
function, and therefore cell function. However, over the past few decades, a few human diseases 
have been linked to defective ribosome biogenesis. Many mutations in proteins and RNA that play 
a role in ribosome biogenesis have been identified as molecular causes for ribosomopathies. 
Characterizing these disorders as ribosomopathies has been difficult due to the large number of 
proteins and RNA that participate in ribosome biogenesis and maturation. These same proteins 
play other roles in the cells metabolism and therefore it is hard to discern if a disease is the result 
of its role in ribosome biogenesis or other cell functions. Although many mutations have been 
linked to different disorders, it has been found that one disease can be caused by multiple mutations 
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in the same or different gene. There have also been no correlations found between mutations and 
certain phenotypes that present themselves. Taking all of this into account, it becomes obvious that 
identifying and characterizing ribosomopathies is a difficult task which we have just begun. 
Another interesting aspect of ribosomopathies, is the tissue-specific effect of improper 
ribosome biogenesis. All the cells within patients suffering from ribosomopathies have the same 
mechanistic dysfunction within their genes. However, different tissues seem to suffer to different 
extents. Although ribosomes and their function are essential in all cells, some cells seem to be 
affected more by altered ribosome biogenesis. Many hypotheses have been proposed to understand 
this phenomenon but a consensus has not been established so far. Some believe that the tissue 
specific affect is due to different tissue having a different tolerance for the activation of p53 (Farley 
and Baserga 2016).   When ribosome biogenesis is disrupted, the amount of activated p53 in the 
cell increases, resulting in cell senescence or apoptosis (Farley and Baserga 2016; Bursac et al. 
2014; Golomb, Volarevic, and Oren 2014). Another hypothesis is based on the presence of 
“specialized ribosomes” (Farley and Baserga 2016; Nakhoul et al. 2014). These ribosomes are 
“specialized” in the sense that they might have modified rRNA and/or have a bound protein that 
is dependent on a specific tissue (Xue and Barna 2012). These specialized ribosomes will then go 
on to translate specialized mRNAs. A different hypothesis ponders that this difference in tissue 
susceptibility is due to tissues having different needs for ribosomes. Fast growing cells and tissues 
will need more ribosomes and therefore have a shorter timeframe to make them. Therefore, cells 
which have an altered ribosome biogenesis pathway and are fast growing and reproducing will be 
more susceptible to the production of improper ribosomes. Due to quick growth, cells will find it 
hard to overcome bottlenecks in ribosome biogenesis arising from a mutation in the pathway. This 
can result in the buildup to ribosomal intermediates which can stimulate the nucleolar stress 
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response, causing either growth arrest or cell death (James et al. 2017). Due to this tissue 
specificity, ribosomopathies are not currently being treated by focusing on the cause, but instead 
are contained by focusing on the effects, or the symptoms that arise in patients.     
A few prevalent illnesses associated with ribosomopathies are anemias, craniofacial 
abnormalities, skin discoloration, and a higher chance of cancers (Armistead and Triggs-raine 
2014; Nakhoul et al. 2014; Narla and Ebert 2010). Some of these diseases are dominant negative, 
while others are autosomal recessive. Most of ribosomopathies are rare within the population and 
are quickly identified in newborns. To understand ribosomopathies better, we first must focus on 
ribosome biogenesis and identify the areas where the pathway might be susceptible to mutations 
that disrupt biogenesis, but not necessarily make it impossible.   
Eukaryotic Ribosome Biogenesis 
 Our current understanding of eukaryotic ribosome biogenesis comes from the study of the 
yeast Saccharomyces cerevisiae (Kressler, Hurt, and Ba 2017). Most of the energy consumed by 
a eukaryotic cell is focused on ribosome biogenesis (James et al. 2017). In Eukaryotes, the 
ribosome is composed of four rRNA molecules, 18S rRNA in the small subunit (SSU), and 25S, 
5.8S, and 5S rRNA in the large subunit (LSU). These rRNAs are bound by 80 r-proteins (Kressler, 
Hurt, and Ba 2017). The SSU is bound and molded by 33 r-proteins (names starting with RPS), 
while the LSU is bound by 47 r-proteins (names starting with RPL). These four rRNAs and 80 
proteins make up the mature ribosome. However, during ribosome biogenesis, there are other 
proteins and RNAs that intermittently bind and help to shape, export, and test the ribosome. There 
are over 200 proteins which bind and come off the ribosome during biogenesis which are called 
assembly factors (Kressler, Hurt, and Ba 2017; Nerurkar, Altvater, and Gerhardy 2015; Tomecki, 
Sikorski, and Zakrzewska-placzek 2017). In total, there are more than 350 proteins that are 
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involved in eukaryotic ribosome biogenesis (Nerurkar, Altvater, and Gerhardy 2015).  
The DNA encoding 18S, 25S, and 5.8S rRNAs is transcribed as a single 35S by RNA 
Polymerase I in the nucleolus. While the DNA encoding the 5S rRNA is located outside the 
nucleolus and is transcribed by RNA Polymerase III (Kressler, Hurt, and Ba 2017). The r-proteins 
mRNA is transcribed by RNA Polymerase II, which shows that ribosome biogenesis is dependent 
on all three RNA Polymerase that are found in eukaryotes. The 35S rRNA forms the backbone for 
the first ribosome intermediate, the 90S. The 90S intermediate contains most of the r-proteins that 
will be bound to the SSU or the 40S subunit, while having very little of the LSU r-proteins bound. 
The 90S is bound by small nucleolar RNA (snoRNA) which form small nucleolar 
ribonucleoprotein particles (snoRNPs) which perform ribose methylation or pseudouridine 
formation. Subsequently, the 90S intermediate is processed by nucleases which separate the two 
components that will form the SSU and the LSU (Tomecki, Sikorski, and Zakrzewska-placzek 
2017). 
As the ribosome intermediates are formed, they travel from the nucleolus to the 
nucleoplasm and then get transported to the cytoplasm where they mature into the small and large 
subunit (Nerurkar, Altvater, and Gerhardy 2015). These two mature subunits will come together 
to form a functional ribosome. Most of the r-proteins are bound to the SSU intermediate relatively 
early, and as it travels through the nucleoplasm, a few more r-proteins bind and shape the 20S 
rRNA intermediate for its final processing to 18S in the cytoplasm. Export proteins begin to bind 
the pre-40S and allows it to pass through the nuclear pore complex. The pre-40S subunit uses 
general export proteins with the help of Ran-GTP such as Crm1, Mex67/Mtr2, and Rrp12 
(Nerurkar, Altvater, and Gerhardy 2015). No know specific exporter proteins have been identified 
for the pre-40S (Nerurkar, Altvater, and Gerhardy 2015). These export proteins do not only allow 
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the pre-40S to enter the cytoplasm but also protect the yet to be structured nucleotides. After 
export, most assembly factors and export proteins are removed, the pre-40S binds the 60S to form 
a pre-80S complex. During the formation of this complex, the 20S rRNA is processed to the final 
18S rRNA and the 60S is then disassociated (Kressler, Hurt, and Ba 2017). Finally, the whole 40S 
is checked for proper function by assembly factors which probe for the movement of specific 
nucleotides, which then goes on to participate in mRNA translation. 
Unlike the pre-40S, the pre-60S is not formed at all while in the 90S intermediate. Instead, 
the pre-60S formation is dependent on being processed from the pre-40S as well as the 3′ end being 
fully transcribed. LSU r-proteins begin to bind after the rRNA has been fully transcribed with the 
5′ and 3′ ends coming together (Kressler, Hurt, and Ba 2017; Tomecki, Sikorski, and Zakrzewska-
placzek 2017). As r-protein begin to bind in the nucleolus, the rRNA is processed into the 25S and 
5.8S rRNA. The 5S rRNA binds its r-proteins outside the nucleolus and then travels to the 
nucleolus where it interacts with the pre-60S complex. As this pre-60S subunit moves from the 
nucleolus to the nucleoplasm, it binds more r-proteins and assembly factors. It also binds general 
export proteins as mentioned above for the pre-40S, but unlike the pre-40S, a specific export factor 
Nmd3 with a nuclear export sequence (NES) has been identified for the pre-60S subunit (Nerurkar, 
Altvater, and Gerhardy 2015). Binding of Nmd3 marks the pre-60S complex for export to the 
cytoplasm where it is processed to a mature 60S subunit. In the cytoplasm, the pre-60S is bound 
by additional assembly factors in a specific order to disassociate nucleus bound assembly factors 
as well as export proteins. While removing bound assembly factors, these new assembly factors 
test the pre-60S for function before allowing it to enter the pool of mature 60S subunits. Finally, 
the mature 60S and 40S come together on an mRNA which it can begin to translate as a mature 
80S ribosome. 
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 After following the maturation of the eukaryotic ribosome, it becomes clear how mutations 
in certain proteins or RNAs could have a deleterious effect on the structure and function of the 
ribosome. Although it is thought that the SSU and LSU can arrive at their mature structure through 
many paths, only a few of the highly populated intermediate complex have been identified so far, 
showing us that there are checkpoints that need to be reached with any path chosen. Mutations that 
might inhibit one pathway or result in checkpoint lag, will produce accumulated ribosome 
intermediates which will activate the nucleolar stress response. From transcription of ribosomal 
DNA to protein binding, rRNA processing, nucleus export and assembly factor binding and 
probing, there are many points at which ribosome biosynthesis can be influenced by unexpected 
changes in cellular genetics which can lead to ribosomopathies. 
Identified Ribosomopathies 
 There have been approximately ten diseases classified as ribosomopathies whose 
molecular causes have been identified (Nakhoul et al. 2014; Narla and Ebert 2010). Dimond-
Blackfan Anemia is the primary example of a ribosomopathy because it has been recreated in 
mouse and zebrafish models, and its cause has been shown to only be the result of mutations in r-
proteins. All ribosomopathies do not have a long-term cure, instead their symptoms are treated 
with steroids or bone marrow transplants. People suffering from a ribosomopathy usually have a 
blood disorder, in which their red blood cells do not form properly, they do not have the proper 
shape, or lack the progenitor red blood cells. White blood cells have also been affected in some 
ribosomopathies. Patients also have physical defects as well as potential for mental retardation. 
Ribosomopathies increase the chances of contracting cancers such as leukemia. The following is 
a closer look at some of the characterized ribosomopathies.  
Dimond-Blackfan Anemia (DBA): DBA arises due to mutations in both large and small subunit 
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r-proteins (Danilova and Gazda 2015; Nakhoul et al. 2014). Missense, nonsense, splice site 
mutations, and deletions have been found in genes encoding the RPS and RPL genes (Danilova 
and Gazda 2015). All r-proteins mutations that have been characterized in patients are 
heterozygous. RPS19 mutations account for 25% of individuals suffering from DBA. These 
mutations directly affect ribosome biogenesis by influencing r-proteins and their function of 
shaping the rRNA to which they bind. Mutations in RPS19 and RPS24 have been found to increase 
the amount of unprocessed 18S rRNA, which result in decrease of mature 40S production (Narla 
and Ebert 2010). Mutations in RPL genes result in a decrease in 60S production which results in 
an overall reduction in 80S mature ribosomes.  
 Patients suffering from DBA are usually diagnosed within the first year of life due to 
lethargy and a pale complexion. Patients suffer from diseases that arise from a malfunctioning 
bone marrow such as Macrocytic anemia, hypoplastic anemia and a lack of, or absence of red 
blood cell precursors (Narla and Ebert 2010). Some patients exhibit physical abnormalities such 
as short stature, craniofacial and cardiac defects, and thumb abnormalities (Nakhoul et al. 2014). 
Although 18 r-protein genes have been linked to DBA, no correlation has been made between a 
mutation and symptoms exhibited by patients (Danilova and Gazda 2015). This suggests that 
mutations in RPS19 can lead to different phenotypes. DBA patients are also more susceptible to 
developing osteosarcoma or bone cancer. The current treatments for DBA is corticosteroids with 
a bone marrow transplant as a long-term solution. 
5q-syndrome: A subtype of myelodysplastic syndrome (MDS) which is characterized by 
disruption in red blood cell production, 5q-syndrome is the result of deletions in chromosome 5, 
between bands q21 and q23 (Narla and Ebert 2010). It is one of the few non-congenital 
ribosomopathies, that arises at random. This deletion results in patients missing one copy of RPS14 
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gene, which is one of the 33 r-protein that bind 18S rRNA in the 40S SSU. Although one copy of 
RPS14 is present, the haploinsufficiency is enough to prevent the maturation of the 18S rRNA. 
Therefore, ribosome biogenesis becomes bottlenecked at the processing of the rRNA, until the cell 
can translate more Rps14 protein. 
Patients suffering from this disease have enlarged red blood cells or macrocytic anemia, 
and bone marrow cells that do not have the correct nucleus segmentation or hypolobulated 
megakaryocytes. Patients also have either a normal or higher number of platelets, with a 10% 
chance of developing leukemia. Blood transfusions is the main treatment that is used to help 
patients cope, but recently lenalidomide has been shown to decrease the amount of transfusions 
patients need (Danilova and Gazda 2015). Lenalidomide is an analog of thalidomide that is thought 
to improve erythropoiesis, erythroid differentiation, and to inhibit p53, preventing the cell from 
undergoing the nucleolar stress response.   
Schwachman-Diamond syndrome (SDS): SDS is the result of a mutation within the SBDS gene. 
In 90% of patients, both copies of the gene are mutated (Nakhoul et al. 2014). SBDS protein is 
highly conserved in in eukaryotes and is thought to have multiple functions, including mitotic 
spindle stabilization, stress response, RNA processing as well as ribosome biogenesis. SBDS has 
been found to be bound to the pre-60S and its function is necessary to progress the maturation of 
the pre-60S rRNA in the cytoplasm. It is thought to remove EIF6, an export and maturation protein 
of the pre-60S, from the pre-60S with the help EFL1-GTP (Ruggero and Shimamura 2014). Due 
to its many predicted functions in the cell, it has been controversial to assign SDS as a 
ribosomopathy. The phenotypes exhibited by patients might be the result of deregulation of mitotic 
spindles or a lack of RNA processing instead of ribosome biogenesis. However, lymphoblasts that 
 101 
we extracted from patients had a defect in ribosome subunit joining, showing that the 60S is not 
fully matured. 
 Patients suffer from neutropenia or low count of neutrophils, as well as steatorrhea or 
excess fat in feces (Narla and Ebert 2010). Their pancreatic exocrine function is also lower than 
normal, resulting in developmental disorders that lead to short stature, and skeletal deformations 
with cognitive impairments. Patients also have a higher chance of developing cancer. Current 
treatments are blood transfusions, pancreatic enzymes, antibiotics with a definitive treatment being 
bone marrow transplant.  
Dyskeratosis Congenital (DC): DC could arise from mutations in nine different genes. The 
disorder can be autosomal dominant when TERC and TERT are mutated, autosomal recessive 
when TERT and other regulators of non-coding RNAs are mutated, and X-linked when DKC1 is 
mutated (Ruggero and Shimamura 2014). Mutations in non-coding RNA regulators makes up 50% 
of mutated proteins. TERT, which codes for telomerase reverse transcriptase, and TERC, which 
codes for telomerase RNA, both participate in telomeres maintenance. DKC1 or deskerin, adds 
specific DNA sequence repeats to the end of chromosomes. Therefore, it is still controversial to 
include DC in the ribosomopathy category as any identifiable phenotype can be related to the 
deregulation of telomeres (Narla and Ebert 2010). However, DKS1 is known to associate with 
snoRNPs which contain H/ACA small RNAs, that bind to rRNA during transcription and modify 
uridines to pseudouridines. Effectively, DKS1 participates in the modification of rRNAs which 
influence its folding, protein binding, mRNA binding and decoding. The lack of rRNA 
modification might influence the translation of internal ribosome entry site (IRES) containing 
mRNAs, such as the p53 mRNA, leading to a decrease in p53.  
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 Patients are usually diagnosed with DC when they contain three symptoms: a rash or skin 
pigmentation, nail dystrophy, and mucosal leukoplakia or oral white patches. Patients develop 
multiple cytopenias, where they have a low level of red blood cells, neutrophils, platelets, and 
granulocytes. Majority of patients die from bone marrow failure and have a larger chance of 
developing leukemia or solid tumors. Current treatments are steroids and hematopoietic stem cell 
transplantation. However, due to the strain this disorder puts on other organ systems, stem cell 
transplantation has a low success rate.  
Cartilage Hair Hypoplasia (CHH): This is a rare condition that is found in Old Order Amish 
population and Finnish decedents. In the general population, this ribosomopathy is uncommon 
(Nakhoul et al. 2014; Narla and Ebert 2010). The disorder arises due to a mutation in the RMRP 
gene. RMRP does not code for a protein, but instead is the RNA part in the RNase mitochondrial 
RNA-processing complex (RNase-MRP). RMRP is classified as a snoRNA and is localized in the 
nucleolus. It is thought to operate in the maturation the of 5′ end of the 5.8S rRNA. It is also 
believed to participate in small interfering RNA (siRNA) synthesis which go on to influence hair 
development, hematopoietic differentiation and skeletal development (Nakhoul et al. 2014). 
 Patients who have this disease have a lack of hair, short stature or short limbs, and bone 
deformities. Patients are more susceptible to the development of cancers, non-Hodgkin lymphoma, 
and basal cell carcinoma. The current treatment is steroids with stem cell transplant.  
Treacher Collins Syndrome (TCS): TCS arises from mutations within TCOF1 gene. TCOF1 
encodes treacle, a protein that participates in the transcription of rRNAs. It is thought to help RNA 
polymerase I transcribe ribosomal DNA (Armistead and Triggs-raine 2014; Nakhoul et al. 2014; 
Narla and Ebert 2010). TCS has also been identified in patients who have mutated RNA 
polymerase I and III. It is also thought to play a role in the formation of early snRNPs that go on 
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to modify rRNA during maturation. Patients who have TCS have craniofacial abnormalities due 
to defects in the formation of the first and second branchial arches. These craniofacial deformities 
result in troubles breathing, hearing, swallowing and brain development. There are currently no 
treatments for this disease, but symptoms are addressed through surgeries. 
Other Ribosomopathies 
 There are some ribosomopathies that have not been studied or looked at closer like those 
described above. Isolated congenital asplenia is the result of a mutation in the RPSA gene which 
codes for an r-protein which binds the SSU (Armistead and Triggs-raine 2014). Aplasia cutis 
congenital has a mutation in BMS1, a ribosomal GTPase. North American Indian childhood 
cirrhosis (NAIC) is due to a mutation in CIRH1A which is a protein that participates in rRNA 
processing. T cell acute lymphoblastic leukemia arises from mutations in LSU binding r-proteins. 
Mutations in RPL5, 10, and 22 prevent the proper maturation of the 60S subunit. Patients with 
Bowen-Conradi syndrome have a mutated EMG1 gene which plays a role in the methylation of 
pseudouridines. Anauxetic dysplasia is the result of a mutation in RMRP, just like CHH, which 
affects pre-rRNA processing.  
Role of P53 in Ribosomopathies 
 The process of making new mature ribosomal subunits is energy and resource intensive for 
cells and requires constant oversight to make sure the multi-step process is producing proper 
intermediates and functional end products. The cell uses p53 as a detector for the efficiency of 
ribosome biogenesis (Golomb, Volarevic, and Oren 2014). If ribosomes are being produced, p53 
is tagged for degradation by MDM2. If r-proteins and ribosomal intermediates begin to 
accumulate, MDM2 is sequestered by unbound r-proteins resulting in p53 stabilization which 
activates cell cycle arrest and subsequently induce apoptosis. There are current ideas for 
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ribosomopathy therapy involving the removal of p53 from the cell. However, treating patients by 
inhibiting p53 activity makes them susceptible to the development of cancers. One of the ways in 
which it is thought that lenalidomide works in 5q-syndrome patients is by promoting the 
degradation of p53 (Nakhoul et al. 2014). Mouse and zebra fish models of DBA, 5q-syndrome, 
and SDS had their erythroid disorder phenotype rescued when p53 was deleted.  
In normal functioning cells p53 levels are low and the cell follows its cell cycle. The tumor 
suppressor p53 is marked for degradation by its E3 ubiquitin ligase MDM2, whose transcription 
is promoted by p53. It has been found that 5S rRNA in complex with RPL5 and RPL11 sequester 
MDM2, allowing p53 to become active during the activation of “nucleolar stress response” 
(Bursac et al. 2014). It has been shown that deleting either RPL5 or RPL11 can stop p53 from 
becoming activated. Deletion of other r-proteins did not have the same effect on p53, potentially 
showing that the 5S RNP is essential for detecting ribosome progression. As the concentration of 
p53 increases in cells, it tetramerizes and binds DNA to induce transcription of p21(and other 
mRNA) which binds cdk2 to stops the cell cycle. Deletion and mutation in many r-proteins have 
resulted in p53 activation because it leads to the accumulation of ribosomal intermediates which 
cannot be further processed and therefore bound by other r-proteins. Active p53 can also inhibit 
the transcription of rRNA by stopping the activity of RNA polymerase I and III or by activating 
the retinoblastoma tumor suppressor protein which inhibits rRNA synthesis. p53 can also inhibit 
ribosome biogenesis by inhibiting mTOR and c-MYC, and by inhibiting the transcription of 
ribosome export protein CRM1.  
Concluding Remarks 
 Ribosome biogenesis is a major part of the cell life cycle and its efficient performance is 
required for cell growth and division. Previously, it was thought that ribosome biogenesis is an 
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uncompromising aspect of life because protein synthesis is required for life to thrive. The 
discovery of ribosomopathies has highlighted the efficiency of ribosome biogenesis and just how 
important it is for a cell and an organism to have properly formed and matured ribosomes. 
Although an organism can survive with alterations in ribosome biogenesis, it would not be able to 
prosper. There are currently very little treatments available for patients, and potential future 
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